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ABSTRACT 
This study investigates in rats the safety and haematinic efficacy of the two 
plants Grewia tenax and Cajanus cajan. These plants are used traditionally in 
Sudan for the treatment and prevention of iron deficiency anemia. 
Forty Wistar breed rats of both sexes were used (6 weeks old), to evaluate the 
safety and hematinic efficacy of aqueous extracts of either plant. The aqueous 
extract of the whole fruit was used for Grewia tenax, while for Cajanus cajan 
the aqueous extract of the seed was employed. For each plant extract 
experiment, the animals were divided into four groups, each of ten animals. 
Group 1 rats served as untreated controls and were given only distilled water. 
Animals of groups 2, 3 and 4 were treated daily by oral gavage with the aqueous 
extract at the dose of 10, 15 and 20 gm/kg.b.w. respectively.  
The animals were given the respective extract daily for a period of 45 days. 
Then each group was subdivided randomly into two subgroups of five animals 
(subgroups A and B) of either sex. Those of subgroup B continued to take the 
extract for another 45 days, while rats of subgroup A were given distilled water 
for the same period of time. Rats were weighed on day 0, 45 and 90. Blood 
samples  
(2 ml) from each experimental rat were obtained on day 0, 45 and 90 in EDTA 
tubes by bleeding from the ophthalmic venous plexus (orbital sinus). The 
collected blood was used for complete blood counts (CBC). Furthermore, blood 
samples  
(4 ml) were collected on day 90 at necropsy for the purpose of biochemical 
analyses.  
 xii
The results of this study show that the oral administration of different dose 
levels of the whole fruit of Grewia tenax or seed of Cajanus cajan aqueous 
extracts did not produce any toxicological effects. There were no any significant 
differences between tested animals of various groups in blood parameters (RBC, 
WBC and blood platelets counts, HCT percentage, MCV, and MCH) or serum 
biochemical  constituents (Iron concentration, total iron binding capacity, total 
protein, and albumin and the activity of alkaline phosphatase, aspartate 
aminotransferase and alanine aminotransferase) compared with control groups. 
So the results confirmed the safety of the two plants aqueous extracts in Wistar 
breed rats.  
As normal rats were used in this study, the two plant preparations did not 
demonstrate hematinic efficacy on blood constituents especially heamoglobin 
concentration, red blood cells count, iron and iron binding capacity, in spite of 
their high contents of iron and the presence of vitamin C in the seeds of Cajanus 
cajan, which enhance iron absorption. Further investigations are needed to be 
conducted in anemic animals. 
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INTRODUCTION 
Traditional folk medicine has become a topic of global importance and 
interest. According to the World Health Organization (WHO and UNICEF, 
1978), 80% of the world population uses medicinal plants in the treatment of 
diseases and in African countries, this rate is much higher. Current estimates 
suggest that in many developing countries a large proportion of the population 
relies mainly on traditional practitioners and medicinal plants to meet their 
primary healthcare needs, despite the availability of modern medicines. It is 
estimated that 35,000 to 70,000 plant species have at one time or another been 
used in some culture for medicinal purposes (Husain, 1991). 
In addition, medicinal plants have represented a primary health source for the 
pharmaceutical industry. Large quantities are used for the preparation of 
infusions and decoctions both in the countries where traditional medicine is 
still of great therapeutic, social and economic importance, and in the 
production of important pharmaceutical products abroad (Eltohami, 1997). It 
has been estimated that 25% of all prescriptions dispensed in the USA are 
likely to contain one or more constituents derived from higher plants 
(Fransworth and Soejarto, 1985). Some 95 plant species have been listed as 
sources of 121 clinically useful prescription drugs derived from higher plants 
(Fransworth and Soejarto, 1985). 
Use of medicinal plants is expected to continue to expand globally, both in 
allopathic and herbal or traditional medicine. This is being fuelled primarily 
by consumer interest in natural products and remedies, as well as by 
increasing concerns about the possible side effects of allopathic medicine and 
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also due to their basic uses in medicine as a source of therapeutic agents, and 
as raw material base for extraction of semi-synthetic chemicals compounds. 
This upward trend is predicted not only because of population explosion, but 
also due to increasing popularity for natural-based, environmentally friendly 
products. 
Sudan is the largest country in Africa with an area of 2.5 million km2. The 
climate of Sudan ranges from completely arid to tropical zones with a wide 
range of bioclimatic regions. The diversity of the climate of Sudan is 
responsible for its very rich flora. The medicinal and aromatic plants found in 
Sudan are both wild and cultivated (Eltohami, 1997). 
International Trade Center (2001) reported that among a large number of 
Least Developed Countries (LDC) which supply medicinal plants, Sudan is 
the largest exporter, having supplied about 37 % of total (LDC) exports and 
averaging about $27 million per year during 1995-1999.  
The major important markets are the European Union (EU) and United State 
of America (USA).   
Sudan is very rich of its natural resources of the medicinal plants; it should 
have the maximum benefits of these resources especially in the treatment of 
the diseases that have negative economic impact, like most types of anemia.  
Anemia can be caused by iron deficiency, folate deficiency, vitamin B12 
deficiency and other causes Tom Brody, (1998).  Iron deficiency anemia is 
the most common type of anemia, 66% of children and women aged 15 – 44 
years in developing countries have it, while 10 – 20% of women of 
childbearing age in developed countries are anemic (Scrimshaw, 1991). This 
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is in accordance with the WHO prevalence estimates of anemia throughout the 
world (WHO, 1998). 
The goal of iron intervention is to move at-risk groups to a level of nutritional 
sufficiency compatible with good health. Iron deficiency cannot be effectively 
addressed by one or two actions. Under most real life situations there is no 
single effective intervention for the elimination of iron deficiency.  
An appropriate set of intervention strategies must be selected, weighed, 
integrated and adapted to the needs of different populations, environments and 
the availability of resources, (WHO, 1998) .   
This study was planned to investigate the safety and efficacy of two local 
Sudanese plants, Grewia tenax and Cajanus cajan, in healthy Wistar breed 
rats. These plants are used traditionally in the Sudan for the treatment and 
prevention of iron deficiency anemia. 
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Objectives 
 The objectives of this study were: 
1- To investigate the safety of the aqueous extracts of the Grewia tenax 
fruits and Cajanus cajan seeds in healthy Wistar breed rats. 
2- To evaluate the hematinic efficacy of the aqueous extracts of the 
Grewia tenax fruits and Cajanus cajan seeds in healthy Wistar breed 
rats. 
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CHAPTER ONE 
 
LITERATURE REVIEW 
 
1.1 Anemia 
1.1.1 Definition  
Anemia is defined as a reduction in hemoglobin concentration below the 
normal range for sex and age, accompanied usually but not invariably by 
reduction in red blood cells mass count, (Anderson, 1987). Anemia can be 
caused by iron deficiency, folate deficiency, vitamin B12 deficiency, and  
other causes M.C.S., (2oo5). 
The term iron deficiency anemia is a type of anemia, which is characterized by 
less than adequate iron level in the body (Anderson, 1987). Iron is required in 
relatively high doses to maintain proper nutrition. The nutritional need for iron 
in the living organism is derived from the central role that it plays in energy 
metabolism of living cell, (Martinez, et al., 1999). Every cell in the body 
requires iron for a variety of functions. Iron is involved in oxygen transport 
(hemoglobin) and storage (myoglobin), required by enzymes that produce 
energy for the cell, and it plays an important role in the function of immune 
system and central nervous system (Cook, 1999). Iron is required in relatively 
high doses to maintain proper nutrition, and the recommended daily allowance 
for iron is difficult to obtain from dietary sources. Therefore it is the most 
common single micronutrient deficiency worldwide (DeMayer, 1989).  
The recommended daily intake for iron is 10 -15 milligrams per day, 30 mg 
during pregnancy (NAS, 1990). Consequently, iron deficiency anemia is 
nowadays the world most prevalent nutritional problem, (Szarfare and de 
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Souza, 1997). It seems to be the only micronutrient deficiency that 
industrialized and developing countries have in common (Hambraeus, 1999). 
1.1.2 Aetiology  
Iron deficiency anemia can be caused by too low dietary iron intake or 
complete lack of iron in the diet, low bioavailability which is defined as the 
proportion of a given nutrient in a given food which the body can actually 
utilize (Hambraeus, 1999), increased iron requirement due to physiological 
variables or clinical problems which are not met by an increased dietary intake 
of iron such as pregnancy, lactation and, blood loss (Ernest et al., 2001). 
The normal rate of blood loss in feces is 0.5 – 1.0 ml per day. These losses can 
increase with some diseases which lead to slow chronic blood loss from 
sources within the body, such as peptic ulcer, hiatal hernia, kidney or bladder 
tumor, colon polyps, colorectal cancer, or uterine fibroids (healthAtOZ, 
2005). Also gastrointestinal bleeding from the regular use of some medication 
such as aspirin, nonsteroidal anti- inflammatory drugs (NSAIDS) might lead 
to iron deficiency anemia. Bleeding from hemorrhoids also can be source of 
iron loss and anemia, hookworm infestation can lead to blood loss, and finally 
an inability to absorb iron (healthAtOZ, 2005). 
 Iron from food is absorbed into the blood stream in the small intestine. 
An intestinal disorder such as Crohn's disease, celiac disease or a part of small 
intestine has been bypassed or removed surgically, can affect the ability to 
absorb iron and other nutrient (Annibale, et al., 2001). 
Some medication can interfere with iron absorption such as proton pump 
inhibitors which suppress stomach acid that needed to convert dietary iron into 
a form that can readily be absorbed by small intestine (Ernest et al., 2001). 
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Certain dietary factors can affect absorption of iron like enhancer such as 
heme iron which absorbed more efficiency than non-haem iron, which can 
enhance the absorption of non-heme iron, also vitamin C can enhance the 
absorption of non-haem iron (Lynch, 1981), and inhibitors (oxalic acid, phytic 
acid or phytate, tannic acid found in tea, polyphenols in coffee, Ca and 
Ca3(PO4)2, (Benito and Miller, 1998).  
1.1.3 Development  
Iron deficiency anemia can occur in stages include:  
Stage 1: (iron depletion) takes place when the body's iron stores begin to 
decrease. It is usually evident in the bone marrow only. No symptoms are 
present and hematocrit and hemoglobin are normal.  
Stage 2: (iron deficiency erythropoiesis): 
This is the process by which red blood cells are produced by bone marrow 
cells. Iron deficiency erythropoiesis is the beginning (early sign) of iron 
deficiency. It occurs when there is limited production of red blood cells, 
because there is no stored or insufficient transport of iron in the body (W.I.C., 
2002).  Hematocrit and hemoglobin may be marginal. Symptoms may be mild 
or absent. There is elevation of iron binding capacity of the serum, fall in 
serum iron and developement of normochromic or slightly hypochromic 
anemia. 
 Stage 3: (iron deficiency anemia). Occurs when smaller - than normal red 
blood cells with less hemoglobin are produced (hypochromic microcytic 
anemia) (W.I.C., 2002).  Hemoglobin and hematocrit are low. Symptoms 
depend on how quickly anemia develops; weakness and easy fatigue are the 
symptoms that take place because of the lack or reduced ability of red blood 
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cells to carry iron to the exercising muscles. Dyspnea on exertion, headache, 
pale skin and mucous membranes, heart palpations, varying degrees of 
impairment in cognitive performance, poor learning capacity and reduced 
psychomotor skills, decreased work performance, increased susceptibility to 
infection and inability to stay worm are also of the symptoms characterizing 
this type of anemia. In sever cases other clinical symptoms included 
dysphagia, sore tongue which becomes smooth, shiny and reddened with 
atrophy of the papillae of the tongue and glossitis, brittle nails, pica, shortness 
of breath during or after physical activity, hair loss, fissuring at the angles of 
the mouth. In sever long standing iron deficiency anemia the nails may be 
spoon – shaped and abnormally brittle. Splenomegally may represent 
hyperplasia associated with the long standing hyperhemolysis linked with the 
shortened life span of iron deficient cells, (Ernest et al., 2001). 
Despite all efforts to counter act iron  deficiency,  it is still represents one of 
the dominant problems in micronutrient sphere, and the world most prevalent 
nutritional problem especially in developing countries,   where poor diet 
quality rather than Fe intake seems to be the key determinant of impaired iron 
status . The high rates of iron deficiency anemia most likely reflect an 
inadequate consumption of iron rich food (Hambraeus, 1999). 
 
1.2 Plants with antianemic activity 
Since ancient times, plants have been exemplary source of medicines for 
treatment of various human ailments throughout the world. Many plants have 
been tried for the treatment of iron deficiency anemia. 
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 Piao et al., (2003) afforded an experimental basis for preventing and treating 
anemia after the administration of Shengxuesu (Chinese medicinal plant), at 
the dose of 0.5 – 2 mg/kg by gavage for 15 days to rat model of iron 
deficiency induced by denutrition (hypoferric anemia)  and to the mouse 
model of hemorrhagic anemia induced by blood letting for 7 days. The  results 
of the experiment showed that HB, RBC, HCT,MCHC in blood and iron 
ferroprotein in serum were elevated significantly following treatment with 
Shengxuesu, but total bounding iron in serum was decreased, meanwhile diet 
consumption and general activity of the model rats were increased. 
Furthermore, Haro et al., (2000) described the possible beneficial effect of 
two natural products on the digestive utilization of iron, calcium, phosphorus, 
and magnesium in rats with nutritional ferropenic anemia. They found that the 
addition of pollen and the propolis produced by bees to the diet of rats 
produced a positive effect on weight gain and improved the digestive 
utilization of iron and regeneration efficiency of hemoglobin, especially 
during recovery from anemic syndrome. The two products also have a positive 
effect on phosphocalcic metabolism, and maintained an appropriate level of 
magnesium metabolism furthermore in iron deficient rats these natural 
products palliate to large extent the adverse effect of iron deficiency on 
calcium and magnesium metabolism as a result of the improvement in the 
digestive utilization of these minerals. Hatano et al., (2004) confirmed the 
antianemic effect of the aqueous extract from the root of Angelica acutiloba 
kitagawa (AR), (RA is used in Japan as herbal medicine and has been reported 
to be clinically effective for postmenstrual blood loss, erythropoietin (EPO) 
and resistant anemia in chronic renal failure.) in experimentally anemic mice 
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induced by a bolus injection of 5-Flourouracil (5Fu) at the dose rate of 150 
mg/Kg to mice (8 to 10 week-old female). Anemic mice were then 
administrated orally the water soluble fraction of (AR) for 10 days.  
Gomes et al., (2001) reported the increase of hemoglobin, haematocrit, RBC 
and total WBC in anemic albino rats following the administration of the 
ethanolic extract of the aerial parts of Hygrophila spinosa T. (a semiwoody 
herb from India). In Nigeria, Agbor and Odetola, (2001) investigated the 
effect of aqueous extract of Parquetina nigrescens on hematological 
parameters in anemic rats from which about 30% of blood volume was 
removed through ocular vein under chloroform anesthesia. Anemic rats were 
given P. nigrescens aqueous extract daily for four weeks showed Significant 
progressive and dose related increase in red blood count (RBC) , hemoglobin 
(gm/dl), haematocrit (HCT%) and reticulocyte (%), while a decrease in white 
blood cell count (WBC) was observed compared with both normal and bled 
control rats. Beard, et al., (1996) found that soybean is a rich dietary source of 
iron for treating iron deficiency in anemic rats as compared to purified ferritin. 
Full recovery (89-109%) from anemia and increased tissue iron occurred after 
28 days of treatment with either  iron source, and their data suggest that 
manipulating frerritin expression and other soluble components of seed iron in 
soybeans and possibly other seeds could contribute to a sustainable solution to 
global problem of iron deficiency. These observations are in accordance with 
Shiga, et al., (2003) who showed that feeding of water soluble soybean fiber 
(WSSF) (a highly fermentable diet fiber) improved anemia in gastrectomy- 
induced iron malabsorption, and impairment of exercise performance, in 
totally gastrectomized rats. The dietary intake of Faba bean, which is widely 
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consumed in the Middle East, when given to rats after cooking with (different 
selected Egyptian cooking methods), was able to increase hemoglobin level of 
the blood in rats with different experimental diets containing four faba bean 
products (Bakr and Bayomy, 1997).  
Several studies in humans proved the ability of plants products in the 
prevention and treatment of iron deficiency anemia. In India, Gopaldas, 
(2002) show that iron deficiency anemia can be reduced by increasing the 
consumption of cereal-based fermented foods or gooseberry  juice , and that 
hemoglobin status can easily be improved by cost – effective workplace 
lunches that also lead to better employer – employee relations. Another study 
carried out by (Aslan, et al., 1997) which involved 56 subjects, aged 6 – 36 
months reported that the absorption of iron from grape molasses is comparable 
with ferrous sulfate and suggested the effectiveness of grape molasses as iron 
source in preventing iron deficiency anemia during infancy. 
Branch and da Silva, (1983) documented an antianemic traditional herbal 
remedy preparation of Quassia amara (which is used in Nicaragua, Mexico, 
Nigeria, Turkey and Venezuela). Duke, (1985) recommended Quassia amara 
as excellent folk remedy and the bark is considered to be stomachic and tonic. 
Shah, et al., (2003) measured iron absorption in children from meals 
containing apple or orange juice, in an attempt to determine whether iron 
absorption will be greater with orange juice because of its higher ascorbic acid 
content compared with apple juice, a noncitrus fruit juice. The study 
concluded that regardless of higher ascorbic acid content of orange juice, 
children absorbs iron well from meal that includes either orange or apple juice.  
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An Indian study in which the prevalence of iron deficiency is high due to both 
low iron intake and low availability foods of plant origin, Grewal, et al., 
(2000) investigated the effect of different wheat products on iron availability 
by testing hemoglobin regeneration efficiency using rat model.They found that 
all the minerals including iron and except zinc were higher in whole wheat 
flour while soluble iron was higher in pearled wheat flour. Cooking resulted in 
an increase in soluble iron and neutral detergent fiber. Hemoglobin 
regeneration efficiency (HRE) of pearled wheat flour is higher than whole 
wheat flour and (HRE) of chapatti was higher than parantha (two types of 
local bread). Soluble iron and HRE were significantly associated.       
Trigonella foenum graecum or fenugreek is one of the most ancient medicinal 
plants, used by Egyptians, Greeks and Romans. It used in Italian folk medicine 
as tonic and invigorating in anemia and convalescence (antianemic). Also it 
helps in the formation of blood cells (haemopoietic), (Anagen, 2004). 
El- Shobaki, et al., (1990) were examined the effect of some beverage 
extracts namely anise, mint, caraway, cumin, tilia, and liquorice, on the 
absorption of iron in tied - off intestinal segments of rats. They recommended 
offering these beverages which promoted the absorption of iron that arranged 
in decreasing order of their effect to children and adults as a preventing agent 
to iron deficiency anemia. They also suggested their preparation as a source of 
bioavailble medicinal iron. 
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1.3 Plants used in the present experiments  
1.3.1 Grewia tenax  
It is a fruit producing deciduous tropical shrub or tree, widespread in semi arid 
and sub humid tropical climates. The wild shrub is the main source of the 
growing commercial demand for the fruit. It is considered a prime candidate 
for domestication and commercialization as new crop for the semi – arid 
regions of the Sudan (El-Siddiga, et al, 2003). It occurs on a large area, 
regenerates well and is traditionally protected during clearing and favored by 
farmers. Ecologically it can withstand environmental stress more easily 
compared with annual crops and thus make an important contribution to 
sustainable production without needing expensive inputs of water or fertilizer, 
(El-Siddigb, et al, 2003).  The shrub can give fruits three times a year, if there 
is sufficient rain. If the main crop harvest is delayed its fruits help to fill the 
food gap. Fruits are edible. The ripen fruits are collected and eaten raw. The 
fruits are sweet and may be eaten either as a whole or chewed and only the 
sweet juice is swallowed (E.F.F.F.G., 2005).  Fruits may be pounded, dried 
and stored. Mostly children collect and consume the fruit in normal times, but 
adults may consume as well in food shortage periods (Afar), (E.F.F.F.G., 
2005).  The fruit is an important economic commodity, both locally where it 
used as food and folk medicine and internationally where it has great export 
potential for use in food and pharmaceutical industries (El-Siddiga, et al, 
2003). It has been the subject of much global interest in research and 
development as it might be the solution of worldwide standing problem such 
as iron deficiency anemia (El-Siddigb, et al, 2003). 
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1.3.1.1 Distribution and habitat 
G. tenax is highly drought resistant and occurs in the driest savannas at desert 
margins and regions of higher rainfall, where it grows in thickets on termite 
mounds in otherwise seasonally flooded country. In the Sahel it grows in 
rocky places on hills and slopes, in regions with 100-600 mm of rain per 
annum (Von Maydell, 1986). G. tenax is widespread in Africa from the 
Transvaal and South West Africa to Ethiopia and Arabia in the North - East 
and through West Africa to Senegal. It is only found in the driest types of 
wood land or semi-desert scrub. Geographically distributed in Algeria, 
Botswana, Chad, Djibouti, Ethiopia, Iran, Kenya, Mali, Mauritania, Morocco, 
Namibia, Niger, Nigeria, Saudi Arabia, Senegal, South Africa, Sudan, 
Tanzania, Uganda, Zimbabwe, India, and Pakistan. 
1.3.1.2 Taxonomy  
Current name: Grewia tenax 
Authority: (Forsk.) Fiori 
Family: Tiliaceae  
Synonym(S) 
-Chadara tenax Forsk. 
-Grewia betulifolia Juss. 
-Gerwia chadara Lam. 
-Gerwia erythraea schweinf. 
-Grewia populifolia vahl. 
Scientific name: Grewia tenax (Forssk)fori. 
Other scientific name: Grewia populifolia vahl.  
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The genus was named after Nehemiah Grew (1641-1712), one of the founders 
of plant physiology (Baumer, 1983). 
Common names:  
(Arabic): gaddeim, gaddein, godem, umm ageda. 
(Somali): damak, defarur, dekah, duferu. 
(Wolof):  kel. 
(Ethiopia): Fo(Afargna), Lenkoata (Amargna), Bururi, Dhoqonu, Lensa 
(Oromiffa),Quetata (Agonia).  
In india: gangu Kanger, gangerum, gango, gundu Kadira Kadadari, Kaladi     
,achchu. 
1.3.1.3 Botanic description:  
Grewia tenax is a multistemmed small shrub up to two meters tall usually 
rounded but generally battered and untidy due to browsing. Bark is smooth, 
grey, and very fibrous so that twigs are hard to break. The leaves are oval and 
the tip is pointed or rounded. The edge of the leave is toothed. The vein 
network is very clear below.  Alternate, almost circular in outline, 1.5 - 4 cm 
in diameter, Margins toothed and prominently  tri-nerved at the base, Stipules 
are conspicuous, up to 4mm. long, filiform, pubescent, falling early.  The 
young shoots and the flowers are covered with red – brown hairs. The flowers 
are yellow, purple of white, solitary or in twos or fours axillary placed in a 
terminal head about 5cm. long, the central flowers opening first, with many 
stamens in the center. Petals are white, about 1cm long, but usually much less, 
pubescent, with a linear and often 2- dentate lamina almost as long as the 
sepals and narrower than the basal nectariferous claw which is circumvillous 
within ledged above and up to 1.5 mm long; Sepals long and recurved.  
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The fruit is orange - red at maturity, with 1- 4 spheroid lobes each rounded and 
fleshy about 5mm across, W.A.F.C., (2006), figure 1 and 2 
1.3.1.4 Chemical composition (Sudan sample):  
 Protein (crude) = 6.3% (dry). Fat = 0.4% (dry). Fiber (crude) = 8.1% (dry). 
Ash = 4.5% (dry). Carbohydrate (soluble): Starch = 15.1% dry). Sucrose = 
1.6% (dry). D-glucose = 21.0% (dry). D-fructose = 24.3% (dry). Amino acids 
(g [16g N]-1): Aspartic acid = 8.1g. Threonine = 2.1g. Serine = 2.4g. Glutamic 
acid = 6.2g. Proline = 11.6g. Glysine = 3.5g. Alanine = 2.4g. Valine = 2.8g. 
Cysteine = 1.0g. Methionine = 0.7g. Isoleucine = 2.0g. Leucine = 3.4g 
Tyrosine = 2.5g. Phenylalanine = 2.2g. Lysine = 2.0g. Histidine = 1.1g. 
Arginine = 3.2g. Minerals: Sulphur = 0.10% (dry). Potassium = 0.08% (dry). 
Magnesium = 0.17% (dry). Calcium = 0.61% (dry). Na = 0.01% (dry). K = 
1.45% (dry). Zinc = 21mg/kg-1 (dry). Iron = 74mg/kg-1 (dry). Manganese = 
10mg/kg-1 (dry). Copper = 7mg/kg-1 (dry). The seeds, which are edible, contain 
80% unsaturated oils. Soil types favored by plant – in Sudan: sandy 
depressions, dunes, clay, temporary pools, rocky screes (Famine Foods, 
1998). 
1.3.1.5 Folkloric uses 
In Sudan: G. tenax grows in Kordofan region (Northern and Southern). The 
fruits are eaten fresh or dried for later consumption. A drink is prepared by 
soaking the fruit overnight, and then hand – pressed, sieved, and sweetened. 
Porridge, called (Nesha), is also prepared from this drink by the addition of  
custard and flour then given to mothers to improve their health and lactation, 
(Famine Foods,1998). 
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       Figure 1.1 Grewia tenax natural growth. 
 
 
 
 
 
 
 
 
 
  
 
            
          Figure 1.2 Grewia tenax fruits. 
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In India the orange fruit is usually eaten raw, and leaves are boiled and eaten 
as vegetable. In Ethiopia the ripen fruit is collected and eaten raw either as a 
whole or chewed and only the sweet juice is swallowed, the fruits are always 
collected and consumed between September and April, the leaves are also 
used as animal fodder and the wood can be used as firewood and for 
construction purposes (local construction and farm tools). The bark is 
sometime used to produce local ropes for construction purposes.  The fruit 
contains a large amount of iron. Fruit storage can be extended by drying, the 
dead leaves are eaten but only while they remain on the plant. A mucilaginous 
bark preparation is used by women against hair vermin.  
 
1.3.1.6 Ethnomedical uses  
Anttila et al., (1993) in Kenya studied preference and chemical composition 
of ten indigenous woody plant species used as livestock fodder included 
Grewia tenax. They concluded that milk production and reproduction of cattle 
and small stock had increased by eating these plants and leaves of G. tenax, 
which had the highest protein content (24.91%). Bees visit the flowers of G. 
tenax for pollen and nectar. In Kenya plant parts are used as a remedy for 
colds and chest complaints and also as a chief constituent in Typhoid remedy 
(Von Maydell 1986). 
 
1.3.2 Cajanus cajan (L.) Millsp. 
C. cajan (L.) Millsp. is a leguminous originated in Africa and India. 
Considered it is native to tropical Africa, from Zanzibar to Quinea. It is also 
known as red gram, Congo pea, and Congo bean. Pigeon pea probably evolved 
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in South Asia and appeared about 2000 BC in West Africa, which is 
considered a second major center of origin. The slave trade took it to the West 
Indies, where its use as bird feed led to the name "pigeonpea" in 1692 (Van 
der Maesen 1986). It has been important to the cuisines of India and Ceylon 
for millennia (what it is known as arhar, tur, toor, or tuvaram). It is cultivated 
up to elevations of 2,000 meters in the Himalayas. The pea itself ranges from 
red to white, from brown to black, and it also comes in mottled shades. Most 
often it is found in its dried form. But its delicious fresh pods can be prepared 
as a green vegetable. Interestingly, pigeon peas have a reputation for being 
slightly narcotic, possibly for the especially deep naps after dinner. 
 
1.3.2.1 Distribution and habitat: 
As the species is not found truly in the wild, its natural habitat conditions are 
uncertain. It prefers grassy habitats in tropical, cold-free zones with optimum 
600-1000 mm annual rainfall. However, it grows in humid areas with 2500 
mm annual rainfall and in semi-arid areas with only 400 mm of rain annually. 
It is now grown all over the tropics but especially in the Indian subcontinent 
and East Africa. 
Geographical  distribution includes in India, Indonesia, Myanmar, Pakistan, 
Afghanistan, Angola, Argentina, Australia, Bahamas, Bangladesh, Belize, 
Benin, Bhutan, Brazil, Burkina Faso, Burundi, Cameroon, Colombia, Costa 
Rica, Cuba, Dominica, El Salvador, Eritrea, Ethiopia, Fiji, Ghana, Grenada, 
Japan, Kenya, Madagascar, Malawi, Malaysia, Mauritius, Nepal, New 
Zealand, Philippines, Sri Lanka, Swaziland, Tanzania, Thailand, Uganda, 
United States of America, Zambia, Zanzibar, Zimbabwe and Sudan. 
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1.3.2.2 Taxonomy:  
Current name: Cajanus cajan  
Authority: Druce  
Family: Fabaceae - Papilionoideae 
Synonym(s)  
Cajan bicolor DC.  
Cajan cajan Huth.  
Cajan flavus DC.  
Cajanus indicus Spreng.  
Cajanus striatus Boj.  
Cytisus cajan L.  
Common names: 
(Sudan) : lobia adasi 
(Amharic) : yergib ater, yewof ater 
(Burmese) : pay-in-chong, pe-sinngon 
(English) : angolan pea, Congo pea, no-eye pea, pigeon pea, red gram, yellow 
dhal 
(Filipino) : kadios, kardis, kidis, tabios 
(French) : ambrévade, pois cajon, pois d’Angole, pois pigeon 
(German) : anglische erbse 
(Hindi) : arhar, dhal, shu-tou, tur, tuver 
(Indonesian) : arthar 
(Khmer) : sândaèk dai, sândaèk klnِg, sândaèk kroëb sâ 
(Lao (Sino-Tibetan)) : thwàx h’ê 
(Luganda) : mpinnamiti 
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(Malay) : kacang Bali, kacang gude, kacang hiris 
(Mandarin) : ki-mame 
(Portuguese) : feijo boere 
(Sanskrit) : adhaki, tuvari, tuvarika 
(Spanish) : gandul, gandures, guisante de paloma 
(Swahili) : mbaazi 
(Tamil) : thovaray 
(Thai) : ma hae, thua maetaai, thua rae, togare 
1.3.2.3 Botanic description 
C. cajan (L.) Millsp. is a leguminous shrub that can attain heights of five 
meters.It is a glandular-pubescent, short-lived perennial (1-5 years) shrub, 
usually grown as an annual, 0.5-4 m high, with thin roots up to 2 m deep; 
stems up to 15 cm in diameter; branches many and slender. Leaf is rachis 1-2 
cm long; petiole half as long or less; stipules acuminate, 2.5-5 mm long, 
persistent; leaflets are lanceolate or narrowly elliptic, puberulent above and 
underside, the largest to 7.5-8 x 2.8-3.5 cm, acute apically, bases similar, 
venation strongly reticulate, prominent underneath. Inflorescence axillary from 
a single peduncle, terminating at the insertion of 1-2 pedicels or continuing for 
1-3 additional nodes, rarely branching, usually slightly shorter than the leaves, 
mostly with 2-6 flowers; bracts about 5 mm long; flowers about 2 cm long; 
pedicels to about 9 mm long; calyx tube 3-5 mm long, glandular and 
pubescent, the upper lobe bifid, the lower lobe longest, about 4 mm long; 
vexillary petal basally inflexed biauriculate, mostly with reddish striate, 
bicallose in the target area, glabrous, about 14 mm long, with a claw about 4 
mm long. Fruit a pod, linear-oblong, apex obtuse or acute, compressed, 
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bivalved, depressed between the seeds, about 4 cm long, 1 cm wide, 3-4 mm 
thick; upper suture swollen, the lower indistinct; beak downcurved; seeds 1-5, 
compressed, about 6 x 4 x 1.5 mm, of various colours; the hilum linear-oblong 
to somewhat elliptic, about 3 mm long. 
Leaves are trifoliate and spirally arranged on the stem. Flowers occur in 
terminal or axillary racemes, Pods are flat, usually green in color, sometimes 
hairy, sometimes streaked or colored dark purple, with 2-9 seeds/pod. Seeds 
are, widely variable in color, 6-9 nun in diameter, and weigh 4-25 g/100 seed 
(Duke 1981, Sheldrake 1984). Cajanus is now recognized as having 32 
species. W.A.F.C., (2006), figure 1.3 and 1.4 
Part used: Leaf, flower, bean/seed 
. 
1.3.2.4 Chemical composition  
Chemical analysis reveals guandu contains: 2'-0'methylcajanone, 2'-
hydroxygenistein, 5,7,2'-trihydroxyisoflavone, alpha-amyrin, beta-amryin, 
beta-sitosterol, cajaflavanone, cajaisoflavone, cajanin, cajanone, cajaquinone, 
concajanin, ferreirin, genistein, isogenistein-7-0-glucoside, lupeol, 
phenylalanine, stigmasterol. Analysis of dhal (without husk) gave the 
following values: moisture, 15.2; protein, 22.3; fat (ether extract), 1.7; mineral 
matter, 3.6; carbohydrate, 57.2; Ca, 9.1; and P, 0.26%; carotene evaluated as 
vitamin A, 220 IU and vitamin B1, 150 IU per 100 g. Sun-dried seeds of 
Cajanus cajan are reported to contain (per 100 g) 345 calories, 9.9% 
moisture,19.5 g protein, 1.3 g fat, 65.5 g carbohydrate, 1.3 g fiber, 3.8 g ash, 
161 mg Ca, 285 mg P, 15.0 mg Fe, 55 mg b-carotene equivalent, 0.72 mg 
thiamine, 
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          Figure 1.3 Cajanus cajan natural growth. 
 
 
 
 
 
 
 
 Figure 1.4 Cajanus cajan seeds. 
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0.14 mg riboflavin, and 2.9 mg niacin. Immature seeds of Cajanus cajan are 
reported to contain per 100 g, 117 calories, 69.5% moisture, 7.2 g protein, 0.6 
g fat, 21.3 g total carbohydrate, 3.3 g fiber, 1.4 g ash, 29 mg Ca, 135 mg P, 1.3 
mg Fe, 5 mg Na, 563 mg K, 145 mg b-carotene equivalent, 0.40 mg thiamine, 
0.25 mg riboflavin, 2.4 mg niacin, and 26 mg ascorbic acid/100 g. Of the total 
amino acids, 6.7% is arginine, 1.2% cystine, 3.4% histidine, 3.8% isoleucine, 
7.6% leucine, 7.0% lysine, 1.5% methionine, 8.7% phenylalanine, 3.4% 
threonine, 2.2% tyrosine, 5.0% valine, 9.8 aspartic acid, 19.2% glutamic acid, 
6.4% alanine, 3.6% glycine, 4.4% proline, 5.0% serine with 0 values for 
canavanine, citrulline and homoserine. Methionine, cystine, and tryptophane 
are the main limiting amino acids. The oil of the seeds contains 5.7% linolenic 
acid, 51.4% linoleic, 6.3% oleic, and 36.6% saturated fatty acids. Seeds are 
reported to contain trypsin inhibitors and chymotrypsin inhibitors. Fresh seeds 
contain vitamins, especially provitamin A and vitamin B complex. Per a 100 g 
edible portion, dry seeds contain 7-10.3 g water, 14-30 g protein, 1-9 g fat, 36-
65.8 g carbohydrates, 5-9.4 g fibre and 3.8 g ash. The energy content averages 
1450 kJ/100 g. Fresh green forage contains 70.4% moisture, 7.1 crude protein, 
10.7 crude fiber, 7.9 N-free extract, 1.6 fat, 2.3 ash. The whole plant, dried and 
ground contains 11.2% moisture, 14.8 crude protein, 28.9 crude fiber, 39.9 N-
free extract, 1.7 fat and 3.5 ash. (Duke, 1981). 
1.3.2.5 Folkloric uses  
"Pigeon peas are popular food in developing tropical countries. Nutritious and 
wholesome, the green seeds (and pods) serve as vegetable. In India, 
decorticated, split dried peas (dam) are an important protein source. Ripe seeds 
are a source of flour, used split (dhal) in soups or eaten with rice. Dhal 
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contains as much as 22 - 25% proteins, depending on cultivation and location 
and has a good balance of all amino acids except methionine and cystine, 
which are slightly deficient for the human diet (Faris et al, 1987).  Ripe seeds 
may be germinated and eaten as sprouts. Tender leaves are rarely used as a 
potherb. Plants produce forage quickly and can be used as a perennial forage 
crop or used for green manure. Often grown as a shade crop for tree crops or 
vanilla, a cover crop, or occasionally as a windbreak hedge. In Thailand and 
N. Bengal, pigeon pea serves as host for the scale insect which produces lac or 
sticklac. In Malagasy the leaves are used as food for the silkworm. Dried 
stalks serve for fuel, thatch and basketry (Duke, 1983). Pigeon pea is best 
known as a human food, it is always eaten in combination with cereals this 
legume contributes to a nutritionally balanced human food (Reed, 1987). 
Some anti-nutritional factors are present, but are destroyed by cooking. In the 
Caribbean and East Africa, pigeonpeas are eaten green as a vegetable and are 
commercially grown and canned in the West Indies. Vitamin A (470 mg/100g) 
and C (25 mg/100g) contents of vegetable pigeonpeas are five times those of 
green peas (Faris et al., 1987). When grown as a perennial, pods may be 
picked ripe or green for a long time.  
Pigeon pea is an excellent fodder species. Crude protein values of fresh forage 
range from 15-24% (Whiteman and Norton 1981). Its exceptional nutritional 
value and high productivity can give good liveweight gains. 
 In Hawaii, Henke et al., (1940) reported cattle weight gains of 280 kg/ha/yr 
in pure pigeon pea compared with 181 kg/ha/yr in mixed grass pastures over a 
6.5 months grazing period. Foliage is retained well into dry seasons. Although 
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forage production depends on the stage of the crop, growing conditions, and 
management, experimental yields exceeding 50 dry tons/ha/yr have been 
reported in intensively managed cut and carry sole stands (Whiteman and 
Norton 1981). 
 Pigeon pea sticks are an important household fuel in many areas. Productivity 
more than makes up for comparatively poor fuel characteristics (low specific 
gravity and high moisture content). Stick yields of 7-10 dry t/ha/yr are 
routinely reported for medium and early duration lines, and yields of 30 t/ha/yr 
from irrigated, early duration varieties have been reported in India (ICRISAT 
1986). Perennial varieties can produce 10 t/ha/yr of dry material over a 2-3 
year period on good sites. Sticks also produce thatch and basket materials.  
Pigeon pea is modulated with Rhizobium of the cowpea type and is an 
effective green manure crop. Whiteman and Norton (1981) recommend 
incorporating high density plantings at or about the time of flowering. When 
allowed to perennialize, pigeon pea can drop 1.6 dry t/ha/yr of litter in the first 
year (Sheldrake and Narayanan 1979). It is used in folk medicine in West 
Africa and has been proposed as a nurse crop in India (Purseglove 1968).  
In India very young pods are harvested before the seeds are distinct and are 
cooked in curries or used to make relishes. The dry seeds have several 
products such as tempe (a traditional Indonesian food prepared by fermenting 
with a Rhizopus mould then soaked, dehulled and cooked legume seeds), and 
ketchup (pigeonpea sauce, a replacement for soy sauce in Indonesia that is 
made by fermenting C. cajan with Apergillus oryzae),  
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C. cajan flour (mixed with wheat to improve the protein level of baked 
products) and clear noodles of a quality higher than that of mung bean are 
made from dehulled seed. The leaves can provide a good substitute for alfalfa 
in animal feed formulations, particularly in areas not suitable for alfalfa. The 
pods are used as cattle feed but are limited by their low protein and high fibre 
content. They have therefore been used as a roughage source for cattle. C. 
cajan grain has been successfully used for poultry feed. In Hawaii a mixture of 
equal quantities of cracked pigeonpea and cracked maize has been proved the 
best poultry ration (Wallis et al., 1986). Honeybees collect nectar from the 
plant, which is an important honey source. The honey has a distinctive 
greenish hue in the comb. C. cajan sticks are an important household fuel in 
many areas. The heat value is about 1/2 that of the same weight of coal, and it 
has several advantages over traditional trees, such as its rapid growth 
potential, possibility of producing other crops on the same land, and 
production of a seed crop. Farmers sow it instead of grain because of its wood. 
Its productivity levels more than make up for the comparatively poor fuel 
characteristics (Onim 1987). 
In Kenya, it is an important food legume, cultivated commercially for dry seed 
and as a green vegetable. In Zambia, smallholder farmers generally grow it in 
their backyards and around the fields of annual crops. In Uganda, it is 
combined with millet in a cropping system.  
On an experimental basis, C. cajan has been found to produce a pulp for paper 
similar to that of hardwoods, and the pulp might be suitable for making good-
quality writing and printing paper. The branches and stems can be used for 
making baskets. The wood is used in light construction such as in roofing, 
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wattling on carts, tubular wickerwork lining for wells and baskets. C. cajan 
serves as a host for silkworm (in Madagascar) or the lac insect (in northern 
Bengal and Thailand) Duke 1981. 
Extensively covering the ground with C. cajan prevents soil erosion by wind 
and water.  
By using the nitrogen-balance method, it has been proved in northern India 
that long-duration C. cajan can fix up to 200 kg N/ha over a 40-week period. 
The root system is reported to break plough pans, thus improving soil 
structure, encouraging infiltration, minimizing sedimentation and smothering 
weeds. Leaf fall at maturity adds to the organic matter in the soil and provides 
additional nitrogen. It seems to have special mechanisms to extract 
phosphorus from black Vertisol soils. In Southeast Asia, C. cajan is grown as 
a support for vanilla. Due to its hardiness, ability to grow on residual soil 
moisture, and slow early growth, C. cajan is an ideal, non-competitive crop to 
plant with cereals. In traditional cropping systems, it is mixed with cereals, oil 
seeds, short-season pulses or cotton, with the cereal as the main crop and C. 
cajan as the bonus crop (Reddy, et al., 1979). 
 
1.3.2.6 Ethnomedical uses   
Several studies from Panama (Esposito, et al, 1991), and India (Grover, et al, 
2002) reported the use of Cajanus cajan for the treatment of diabetes. 
Morton, (1976) listed many folk medicinal uses for pigeon pea. In India and 
Java, the young leaves are applied to sores, herpes, leprosy and itches, also C. 
cajan can use for colic, convulsions and abdominal tumors.  Indochinese claim 
that powdered leaves help expel bladder stones. Salted leaf juice is taken for 
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jaundice. In Argentina the leaf decoction is prized for genital and other skin 
irritations, especially in females. Floral decoctions are used for bronchitis, 
coughs, and pneumonia. Chinese shops sell dried roots as an alexeritic, 
anthelminthic, expectorant, sedative, and vulnerary. Leaves are also used for 
toothache, mouthwash, sore gums, child-delivery, and dysentery. Scorched 
seed, added to coffee, are said to alleviate headache and vertigo. Fresh seeds 
are said to help incontinence of urine in males, while immature fruits are 
believed of use in liver and kidney ailments, (Duke, 1983). In Peru, guandu is 
called caja or puspo-poroto. There the leaves are prepared in an infusion for 
anemia, hepatitis, diabetes, urinary infections, fever bath, skin infection and 
ulcers, flu, antidote for certain type of poison and yellow fever. The flowers 
are prepared in an infusion for dysentery, and menstrual disorders; and the 
seeds are infused to use as a diuretic. The leaves can be boiled with coarse 
leaves of thyme and cloves and used as a drink to cure venereal diseases. The 
macerated leaves applied externally as deodorant, (The Nature Zone, 1997) 
In Brazilian herbal medicine, the leaves are infused for coughs, fevers and 
ulcers; the seeds are prepared in a tea for inflammation and blood disorders; 
and the flowers are prepared into a tea for upper respiratory infections and 
pain.  
Ezeifeka et al., (2004) reported the antimicrobial activities of both the leaves 
and seeds extracts of Cajanus cajan against a number of microorganisms 
included Staphylococcus aureus, Pseudomonas aeruginosa, Escherichia coli 
and Candida albicans.  Duker-Eshun et al., (2004) showed that bioactivity 
guided fractionation of extracts of roots and leaves of Cajanus cajan afforded 
eight compounds, betulinic acid, biochanin A , cajanol , genistein and 2 – 
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hydroxygenstein , longistylin A and C and pinostrobin. The two stilbenes, 
logistylin A and C, and betulinic acid showed a moderately high in vitro 
activity against the chloroquine – sensitive Plasmodium falciparum strain 
3D7. In Nigeria, Ekeke and Shode, (1990) reported antisickling activity of 
Cajanus cajan after the amino acid analysis which showed that solvent 
extracts of Cajanus cajan L.Millsp. (Fabaceae) seeds (whit species) contain as 
free amino acid as much as 26.3% phenylalanine. Antisickling experiments 
based on the estimated amount of free phenylalanine in methanol (water – 
soluble) extract of the seeds showed that the presence of this amino acid alone 
could count for about 70% of the antisickling potency of Cajanus cajan seed 
extract.  This is in agreement with the observation of Akojie and Fung, 
(1992) who found that  the amount of phenylalanine and hydroxybenzoic acid 
per gram weight of bean was 4.92 mg ± 0.13 mg and 21.0 mg ± 3.0 
micrograms , respectively. Sickling inhibition was observed to be efficient 
with extract which contain a mixture of phenylalanine (0.69 mg / ml) and p-
hydroxybenzoic acid (10.5 micrograms / ml), equivalent to those found in 
bean extract. The additive antisickling effect of both compounds can be 
therapeutically exploited for the treatment of the sickle cell anemia. Similarly, 
Ogoda et al., (2002) reported that the antisickling properties aqueous 
methanol extract (3:1 v / v) of the seeds of Cajanus cajan were concentration 
dependent and the phytochemical screening of the extracts revealed the 
presence of free amino acids, phenolic compounds, tannins, globulins and 
saponins. These results show that the extract has potential use in the 
management of painful episodes experienced by sickle cell patients.  
Lemonica and Alvarenga, (1994), in Brazil reported that the extracts of 
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Acanthospermum hispidum and Cajanus cajan which have been used by 
Brazilian people to induce abortion, increase the number of external 
malformations in Female Wistar rats, and this was related to dose. No internal 
malformations were observed in fetuses at term, but there was a significant 
incidence of fetuses with visceral anomalies. The tendency of the pregnancy to 
continue or terminate did not change with the treatment. 
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CHAPTER TWO 
MATERIALS AND METHODS 
2.1 Materials and experimental designs 
2.1.1 Animals 
Eighty Wistar breed rats of both sexes were used in this study. They were 
obtained from the Laboratory Animal Unit, King Fahd Medical Research 
Center, King Abdulaziz University, Jeddah, Kingdom of Saudi Arabia. 
The animals age was six weeks at the beginning of the study. The average 
body weight was 95-100 grams for males, and 85-100 grams for females. 
Animals were marked on the tail to permit individual and group identification. 
They were housed in groups of five animals of the same sex in polycarbonate 
cages (550 ×330 ×200 mm) and were maintained in a controlled environment 
at room temperature of 22 ± 2˚C and relative humidity of 40-65% and 12hrs. 
Day-and-night cycle. The rats were fed on standard conventional rodents chow 
manufactured by the Grain Silos and Flour Mills Organization, Jeddah, 
Kingdom of Saudi Arabia. The composition of the rodent feed is shown in 
Table 1. The diet was stored in cool and dry place protected from direct 
sunlight. Rats had free access to food and water throughout the day. Before the 
start of the experiments animals were kept in their cages for seven days for 
acclimatization. All animal procedures were performed according to the Guide 
for The Care and Use of Laboratory Animals of the National Institute of 
Health (Fiennes, et al., 1972) and (CCAC, 1993). 
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Table 1: Chemical composition of the diet used in the  
                                feeding of experimental rats 
 
    Component Percentage or 
Concentration 
Crude fat (%) 4.00 
Crude Fiber (%) 3.50 
Ash (%) 
Salt (%) 
6.00 
0.50 
Calcium % 1.00 
Phosphorus (%) 0.60 
Vitamin A (IU/gm) 20.00 
Vitamin D (IU/gm) 2.20 
Vitamin E (IU/Kg) 70.00 
Energy (ME Kcal/kg) 2850.00 
Trace minerals added include: cobalt, copper, 
iodine, iron, manganese, selenium and zinc. 
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2.1.2 Experimental design for Grewia tenax and Cajanus cajan studies 
Eighty rats of either sex were employed in each experiment. Animals were 
randomly assigned to four groups (1, 2, 3 and 4) of ten males and another four 
groups (1, 2, 3 and 4) of ten females. Animals of groups 2, 3, and 4 were given 
the aqueous extract of Grewia tenax or Cajanus cajan as a daily oral dose of ( 
10 gm/kg.b.w., 15 gm/kg.b.w.and 20 gm/kg.b.w., respectively), for a period of 
45 days. The animals of group 1 served as untreated controls given only 
distilled water for the same period. The oral administration of the plant extract 
was done by the intragastric intubation method described by Waynforth, 
(1980), using 15G, 11 cm long blunt-ended needle canula. Then each of the 
treated groups was subdivided randomly into two equal subgroups (A and B) 
of five animals of either sex. Subgroups B continued to take the extract for 
another 45 days, while the subgroup A was given distilled water for the same 
period of time. The animals were observed daily for mortality and any clinical 
or behavioral abnormalities.  
Rats were weighed on day 0, 45 and 90 using electronic digital precision 
balance (Sartorious, Germany).  
2.1. 3 Collection of blood samples 
Blood samples from experimental rats were obtained by bleeding from the 
ophthalmic venous plexus (orbital sinus), under light diethyl ether anesthesia, 
using fine-walled Pasteur pipette 2.5-5cm long with a diameter of 1.0mm as 
described by (Waynforth, 1980). 
 For the purpose of complete blood counts (CBC), blood samples (2 ml) were 
collected on day 0, 45 and 90 using blood collecting tubes containing EDTA. 
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Other blood samples (4 ml) were collected on day 90 in plain tubes separated 
and centrifuged at 900 Xg for 10 minutes.  
Serum was then harvested in screw caped vials and stored at – 20 oC pending 
biochemical analysis within two weeks. 
 Sera were analyzed for the activities of alanine aminotransferase (ALT), 
aspartate aminotransferase (AST), alkaline phosphatase (ALP) and for the 
concentration of iron, total iron binding capacity (IBCT), total protein (TP), 
albumin (ALB), blood urea nitrogen (BUN), and creatinine (CR).  
Following blood collection on day 90, all animals were sacrificed. Post 
mortem examination was made to all animals for any gross abnormalities. 
Liver, heart, spleen, kidney and the upper part of the femur were removed 
from every animal and weighed. Small pieces from these organs were 
immediately immersed in 10% neutral buffered formolsaline (v/v) for further 
histopathological processing. 
 
2.1.4 Preparation of plant extracts 
The fruits of Grewia tenax and the seeds of Cajanus cajan used in this study 
were purchased from the Market of Seeds and Grains in Omdurman, Sudan. 
The plants were authenticated by the Department of Botany, The National 
Council for Research, Sudan. 
2.1.4.1 Grewia tenax aqueous extract 
Ripen fruits of the plant were washed and allowed to dry at room temperature. 
500 grams of the fruits were soaked in distilled water placed in a 1-liter beaker 
with the volume completed to 1 litre. The beaker was covered with aluminum 
foil and left overnight in the refrigerator at 4 oC. The macerated fruits were 
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then filtered through a coarse sieve. The filtrate was then collected in 1 liter 
volumetric flask and concentrated in a water bath at 30 oC till the volume 
reached 500 ml. A stock solution of the concentrate prepared was equivalent to 
one gram of the fruit in one ml of solution. The stock solution was stored in 
the refrigerator at 4 oC for administration to rats within a maximum period of 
two days. The intended doses were freshly prepared daily before dosing to rats 
by dilution from the stock solution using distilled water. 
2.1.4.2 Cajanus cajan seeds aqueous extract 
Aqueous extract of the seed of Cajanus cajan was prepared by soaking 500 
grams of the clean seeds in distilled water for two hours in a 1-liter beaker and 
the volume was completed to 1 litre. The soaked seeds were then boiled for 
two hours. The extract was filtrated while it was still hot using Whatman No. 
(1) filter paper. The filtrate was concentrated by evaporation at low 
temperature of 30˚C in a water bath.  
A stock solution equivalent to one gram of the seed in 1 ml of solution was 
prepared by additing distilled water to the concentrated solution. The stock 
solution was stored in the refrigerator at 4 oC until used within 48 hours. The 
intended doses were prepared from the stock solution by dilution of the stock 
solution using distilled water. 
 
2.2 Methods 
2.2.1 The hematological analysis 
 Hematological analyses were performed using Beckman coulter LH750 
(Germany/ U.S.A).  
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2.2.1.1 Coulter instrumentation 
Coulter instruments typically have two measurements channels in the 
hydraulics system for determining the hemogram data. The RBC and WBC 
counts and the hemoglobin (HGB) determination are considered to be 
measured directly. The aspirated whole blood sample is divided into two 
aliquots and mixed with an isotonic diluent. The first dilution is delivered to 
the RBC aperture bath, and the second is delivered to the WBC chamber, both 
the RBC and the Platelets (PLTs) are counted and discriminated by electrical 
impedance as the cell are pulled through each of three sensing aperture (50-µm 
diameter  , 60-µm length). Particles between 2 and 20 fL are counted as 
platelets, and those greater than 36 fL are counted as RBCs. A reagent to lyse 
RBCs and release hemoglobin is added to the WBC dilution before the WBCs 
are counted by impedance in each of three sensing aperture (100-µm diameter, 
75- µm length) in the WBC bath. After the counting cycles are completed the 
WBC dilution is passed to the hemoglobinometer for hemoglobin 
determination (light transmittance read at a wave length of 525 nm). The 
electrical pulses obtained in counting cycles are sent to the analyzer for 
editing, coincidence correction, and digital conversion. Two of the three 
counts obtained in both the RBC and the WBC baths must match within 
specific limits for the counts to be accepted by the instrument Hialeah, FL; 
Coulter Electronics, (1983), Hialeah, FL; Coulter Corporation, (1992). The 
digital information obtained from each aperture is channelized by pulse height 
analyzers; 256 channels are used for WBC and RBC analysis, and 64 channels 
are used for platelet analysis. Size distribution histograms of WBC, RBC, and 
platelet populations are generated. The RBC mean cell volume (MCV) is the 
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average volume of the RBCs taken from the size distribution data. The 
hematocrit (HCT), mean cell hemoglobin concentration (MCHC) is calculated 
from measured and derived values. The RBC distribution width (RDW) is 
directly calculated from the histogram as the coefficient of variation (CV) of 
RBC volume distribution, with reference range of 11.5 – 14.5%, Hialeah, 
(1983), (Table 2). 
 
2.2.2 Biochemical analysis 
The reagents used for biochemical analysis were purchased from DADE 
BEHRING (Newark, U.S.A.).  
The serum samples were used for the quantitative analyses of total protein 
(TP), albumin (ALB), iron, total iron binding capacity (IBCT), blood urea 
nitrogen (BUN), creatinine (CR), alkaline phosphatase (ALP), aspartate 
aminotransferase (AST) and alanine aminotransferase (ALT). All biochemical 
analyses were performed using the Automated Clinical Chemistry Analysis 
System, Dimension ® type RxL Max (DADE BEHRING, Deleware, DE 
19714, U.S.A). Sampling, reagent delivery, mixing, processing and printing of 
results were automatically performed by the system. 
 
2.2.2.1 Determination of total protein concentration (TP) 
The total protein concentration determination procedure is a modification of 
the Biuret reaction method first described by Kingsley, (1942) and later 
modified by Henry, (1957).   
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Table 2: Summary of the methods for hemogram 
determination on hematology instrument. 
 
Parameter Method 
WBC Impedance 
RBC Impedance 
HGB Modified 
         Cyanmethemoglobin 
                   (525 nm) 
HCT (RBC × MCV) ÷ 10 
MCV     Mean of RBC size 
    Distribution histogram 
MCH (HGB  ÷ RBC) × 10 
MCHC (HGB  ÷ HCT) × 100 
PLT Impedance (2 – 20 fL): 
 Least square fit of size 
distribution Histogram (0 – 70 fL) 
RDW CV (%) of  
   RBC histogram: 
(SD ÷  MCV) × 100 
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O O R 
OH-
(Absorbs at 600 nm) 
PH 4.9
(Absorbs at 540 nm) 
It is represented as the method of choice for serum protein concentration by 
Henry, (1974). 
In this method cupric ion (Cu++) reacts with the peptide Linkages 
(-C –NH –CH –C –NH -) of protein in a basic solution. 
 
The blue copper (11) protein complex thus formed is proportional to the total 
protein concentration in the sample and is measured using bichromatic (540-
700 nm) endpoint technique. 
         Cu++ + protein            complex                    
 
 
2.2.2.2 Determination of serum albumin concentration 
The albumin method is an adaptation of the bromocresol purple (BCP) dye-
binding method reported by Louderback, et.al, (1968) and Carter, (1970). 
In the presence of solubilizing agent, BCP binds to albumin at pH 4.9. The 
amount of albumin-BCP complex is directly proportional to the albumin 
concentration.  
The complex absorbs at 600 nm and is measured using polychromatic (600, 
540, 700 nm) endpoint technique. 
Albumin + BCP dye   Albumin –BCP complex  
 
2.2.2.3 Determination of serum iron concentration 
Serum Iron concentration was determined by the method developed by Smith 
et al., (1984). The method is carried out under acidic conditions (pH 4.5). Iron 
bound to protein transferrin is released in the presence of the reducing agent, 
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ascorbic acid. The resulting product, Fe++, forms a blue complex Ferene. The 
absorbance of the complex, measured using a bichromatic (600-700 nm) end 
point technique, is proportional to the concentration of transferrin-bound iron 
in the serum.  
Fe+++- transferrin → Fe++++ transferrin  
2 Fe++++ Ascorbic Acid → 2 Fe++ + Dehydroascorbic Acid + 2H+ 
Fe+++ 3 Ferene ® → Fe++ - Ferene ® complex (absorbs at 600 nm) 
2.2.2.4 Determination of total iron binding capacity (IBCT) 
Total iron binding capacity (IBCT) is a measure of the serum transferrin iron 
binding capacity.  
In this method, saturating iron is added to the sample to saturate the transferrin 
iron-binding sites. The excess unbound iron is photometrically determined in a 
manner similar to those described by Yamanishi, (1997). Subsequent addition 
of acid causes the release of bound iron from transferrin which is then 
analyzed using the chromogen Ferene®.  
The serum sample is automatically mixed with ferric iron solution, which 
saturates all available iron-binding sites of transferrin. Under non-acidic 
conditions (pH 8.6), only unbound, excess saturating iron is available to be 
reduced to ferrous iron by ascorbic acid and to form a blue complex with 
Ferene®. Subsequent addition of acid (final pH 4.5) releases the iron bound to 
transferrin; this additional iron is reduced to ferrous iron by ascorbic acid and 
forms an increased amount blue complex with Ferene®. The increase in 
absorbance upon shifting from PH 8.6 to pH 4.5 measured using a bichromatic 
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pH 8.6 
pH 4.5 
Urease 
GLDH 
(600-700 nm) endpoint technique, is proportioned to the total concentration of 
transferrin-bound iron, and thus to the iron binding capacity of the serum.  
 
Transferrin + Fe+++                                                     Fe+++ - transferrin + Fe+++   
Fe++++ Ferene® + Ascorbic Acid                                   Dehydroscorbic Acid +  
      2H+ + Fe++- Ferene® complex 
        (absorbs at 600nm) 
Fe+++- transferrin                                                       transferrin + Fe+++ 
2 Fe++++ Ferene® + Ascorbic Acid                         dehydroscorbic acid + 2H++  
                                                                                          Fe++- Ferene® complex                              
                                                                                                 (Absorbs at 600nm) 
2.2.2.5 Determination of blood urea nitrogen (BUN) 
Blood urea nitrogen was estimated by coupled enzymatic technique which was 
previously described by Talke, et al., (1965). The urea nitrogen employs a 
urease/glutamate dehydrogenase enzyme system. Urease specifically 
hydrolyzes urea to form ammonia and carbon dioxide. The ammonia is used 
by the enzyme glutamate dehydrogenase (GDH) to reductively aminate α- 
Ketoglutarate (α-KG), with simultaneous oxidation of reduced nicotinamide-
adenine dinucleotide (NADH). The change in absorbance at 340 nm due to the 
disappearance of NADH is directly proportioned to the BUN concentration in 
the sample and is measured using bichromatic (340-383nm) rate technique. 
Urea + H20 2 NH3 + CO2     
 
NH3 + α – KG + NADH L- glutamate + NAD 
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pH 10.35 
Mg/Zn 
2.2.2.6 Determination of creatinine concentration 
Creatinine is generally considered as the most useful endogenous substance to 
measure, for the assessment of kidney function. The creatinine method is a 
modification of kinetic Jaffe reaction reported by Larsen, (1972).  
In the presence of a strong base such as NaOH, picrate reacts with creatinine 
to form a red chromophore. The rate of increasing absorbance at 510 nm due 
to the formation of this chromophore is directly proportioned to the creatinine 
concentration in the sample and is measured using a bichromatic (510, 600 
nm) rate technique.  
Creatinine + picrate              red chromophore  
                                                   (Absorbs at 510 nm) 
 
2.2.2.7 Determination of alkaline phosphatase 
The alkaline phosphatase method is based on a procedure published by 
Bowers and McComb, (1966) and more recently reviewed by Rej, (1977).  
Alkaline phosphatase catalyzes the transphosphorylation of p-
nitrophenylphosphate (p-NPP) to p-nitrophenol (p-NP) in the presence of the 
transphsphorylating buffer, 2 amino- 2- methyl- 1- propanol (AMP). The 
reaction is enhanced through the use of 
magnesium and Zinc Ions. The change in absorption at 405 nm due to the 
formation p-NP is directly proportional to the ALP activity, which is measured 
using  
bichromatic (405, 510 nm) rate technique. 
 
p- NPP+ AMP    p- NP+ AMP+ PO4  
 44
  AST 
PH 7-8
MDH 
 
2.2.2.8 Determination of the activity of aspartate aminotransferase (AST) 
The aspartate aminotransferase method is an adaptation of the methodology 
recommended by the International Federation of Clinical Chemistry (IFCC) as 
described by Saris, (1978).  
AST catalyzes the transamination from L-asparate to α – ketoglutarate, 
forming  
L-glutamate and oxalacetate. The oxalacetate formed is reduced to malate by 
malate dehydrogenase (MDH) with simultaneous oxidation of reduced 
nicotinamide adenine dinucleotide (NADH). The change in absorbance with 
time due to the conversion of NADH to NAD is directly proportional to the 
AST activity and is measured using a bichromatic (340, 700 nm) rate 
technique. 
L-aspartate + α – ketoglutarate L-glutamate + oxalacetate 
 
Oxalacetate + NADH                                            Malate + NAD 
 
2.2.3.9 Determination of the activity of alanine aminotransferase (ALT) 
The activity of ALT was estimated according to the method described by 
Bergmeyer et. al., (1978). The procedure is based on the principles outlined 
by Wroblewski and LaDue, (1956). ALT catalyzes the transmination of L-
alanine to α-Ketoglutarate (α-KG), forming L-glutamate and pyruvate. The 
pyruvate formed is reduced to Lactate by Lactate dehydrogenase (LDH) with 
simultaneous oxidation of reduced nicotinamide adenine dinucleotide 
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ALT 
 
pH 7-4
(NADH). The change in absorbance is directly proportional to the ALT 
activity and is measured using a bichromatic (340,700 nm) rate technique 
 
L-alanine + α–KG                                              L-glutamate + pyruvate 
Pyruvate + NADH (H+) Lactate + NAD  
 
2.2.3 Histological processing 
At necropsy samples from the liver, heart, spleen, kidney and femur were 
fixed in formalsaline. Samples were embedded in paraffin wax. Paraffin 
sections were cut at thickness of 5 µm and then stained with haemotoxylin and 
eosin for the histological examination under the light microscope.  
 
2.2.4 Statistical analysis 
Obtained data was examined for normality of distribution using one sample 
Kolmogorov-Simirnov Test. Large significance values of the test (> 0.05) 
were taken to indicate that the observed distribution corresponds to the normal 
distribution. For normally distributed data means are presented as arithmetic 
means ± S.D and compared using statistical test procedures that assume 
normality i.e. Paired-Sample t-test to compare two dependent sample means. 
 P values of less than 0.05 were considered significant. (Snedecor and 
Cochran, 1989).  
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CHAPTER THREE 
RESULTS 
3.1 Safety and haematinic efficacy of the aqueous extract 
 of Grewia tenax  fruit in Wistar rats 
3.1.1 Clinical signs 
All the tested rats of both sexes, in groups 2, 3, 4, and in the control group, 
showed no clinical abnormality or change in behavior during the whole 
experimental period, which extended for three months. No mortalities were 
recorded throughout the period of the experiments.  
3.1.2 Changes in body weights and the weights of some internal organs 
In all groups, male and female rats increased steadily in their body weights in 
a similar way according to their age (Figs. 5 and 6) till the end of the 
experiment. There were no significant differences between the various groups 
in body weights of rats at any occasion of weight determination.  Tables 3 and 
4, showed no significant differences in the weights of Livers, Kidneys, Hearts 
and spleens of male and female rats of the different groups, respectively.  
 3.1.3 Pathological changes   
At necropsy, all tested and control groups of male and female rats exhibited no 
gross post-mortem changes following their sacrifice at the end of the 
experimental period. Normal appearance and texture of all internal organs 
were observed in all experimental groups for both sexes. 
3.1.4 Histopathological changes 
No histopathological changes were seen for all organs been examined for all 
tested and control groups of either sex.  
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Figure: 5. Average growth curve of male Wistar rats orally dosed with Grewia tenax 
whole fruit extract for 45 or 90 days. 
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Figure: 6. Average growth curve of female Wistar rats orally dosed with Grewia tenax 
whole fruit extract for 45 or 90 days. 
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Table 3: Average (mean ± s.d) weights (gm) of some vital organs of male Wistar rats orally 
dosed with Grewia tenax whole fruit aqueous extract for 45 or 90 days  
 
 
       
 
 
 
 
 
 
 
 
 
            All mean values of organs were not significantly (P > 0.05) different from the control value.                                         
Group (1) control Group 2 (10 gm / kg.b.w.) Group 3 (15 gm / kg.b.w.)) Group 4 (20 gm / kg.b.w.) 
 
  A   B   A   B   A   B   
Liver  8.3 ± 0.22 9.2 ± 0.76  9.7 ± 0.42 9.6 ± 0.19 9.1 ± 0.47  9.4 ± 0.53 9.7 ± 0.59 
Kidney 2.0 ± 0.06 2.1 ± 0.16 2.2 ± 0.07 2.2 ± 0.07 2.1 ± 0.20  1.9 ± 0.10 2.2 ± 0.09 
Heart  1.2 ± 0.24 1.1 ± 0.06 1.0 ± 0.04 1.1 ± 0.08 1.2 ± 0.05 1.1 ± 0.04 1.1 ± 0.10 
Spleen  0.5 ± 0.02 0.5 ± 0.04 0.5 ± 0.06 0.6 ± 0.07 0.6 ± 0.04 0.5 ± 0.05 0.6 ± 0.06 
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Table 4: Table 3: Average (mean ± s.d) weights (gm) of some vital organs of female Wistar 
rats orally dosed with Grewia tenax whole fruit aqueous extract for 45 or 90 days  
 
 
 
 
 
 
 
           All mean values of organs were not significantly (P > 0.05) different from the control value.                                          
 
        
Group (1) control Group 2 (10 gm / kg.b.w.) Group 3 (15 gm / kg.b.w.) Group 4 (20 gm / kg.b.w.) 
 
  A   B   A   B   A   B   
Liver  6.2 ± 0.16 6.1 ± 0.24 6.7 ± 0.09 5.6 ± 0.29 6.6 ± 0.13 6.1 ± 0.17 5.9 ± 0.18 
Kidney 1.4 ± 0.05 1.4 ± 0.03 1.4 ± 0.02 1.4 ± 0.04 1.5 ± 0.02 1.5 ± 0.05 1.5 ± 0.06 
Heart  0.8 ± 0.05 0.8 ± 0.03 0.8 ± 0.04 0.8 ± 0.03 0.9 ± 0.04 0.8 ± 0.06
  0.8 ± 0.04 
Spleen  0.4 ± 0.02 0.4 ± 0.04 0.4 ± 0.06 0.1 ± 0.03 0.4 ± 0.03 0.4 ± 0.03 0.6 ± 0.11 
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3.1.5 Hematological findings  
The complete blood counts for male and female rats groups, which were 
treated for 45 days (Table 5 for male rats and Tables 6 for female rats), or 90 
days (Table 7 for male rats and Table 8 for the female rats) showed no 
significant differences between mean values of all the hematological 
parameters (RBC, WBC , blood platelets counts, HCT percentage, MCV, and 
MCH) for the various groups treated with the different dose levels of the 
aqueous extract of the fruit of Grewia tenax compared with the control group 
of the respective sex.  
3.1.6 Serum biochemical changes  
No significant changes were observed between the tested groups with various 
dosage levels of the plant fruit extract and the control group for all the 
biochemical parameters (Iron concentration, total iron binding capacity, total 
protein, and albumin and the activity of alkaline phosphatase, aspartate 
aminotransferase and alanine aminotransferase) been estimated in the serum 
of animals at the end of the experiment for the male rats (Table 9) and female 
rats (Table 10).  
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Table 5: Average (mean ± s.d.) haematological values in Wistar male rats orally dosed with Grewia tenax whole fruit aqueous extract 
for 45 days. 
 
 Group (1) Control  Group (2) 10 gm / Kg.B.W.  Group (3) 15 gm / Kg.B.W.  Group (4) 20 gm / Kg.B.W.  
 Day (0) Day (45) Day (90) Day (0) Day (45) Day (90) Day (0) Day (45) Day (90) Day (0) Day (45) Day (90) 
RBC (x10.e6/uL) 5.9 ± 0.26 8.4 ± 0.17 9.20 ± 0.19 5.3 ± 0.35 7.9 ± 0.09 8.8 ± 0.12 5.7 ± 0.56 7.6 ± 0.40 8.9 ± 0.22  5.8 ± 0.25 8.2 ± 0.19 8.8 ± 0.07 
HGB (g/dL) 9.6 ± 0.48 13.7 ± 0.32 14.9 ± 0.34 8.62 ± 0.476 13.9 ± 0.19 15.2 ± 0.05 9.0 ± 0.88 13.2 ± 0.56 14.9 ± 0.42  9.2 ± 0.49 13.6 ± 0.87 14.9 ± 0.39 
HCT (%) 27.5 ± 1.59 39.5 ± 1.18 47.5 ± 1.16 24.30 ± 1.844 38.9 ± 0.61 44.8 ± 0.17 26.7 ± 2.70 37.0 ± 2.40 45.0 ± 1.77  26.9 ± 1.40 40.4 ± 1.70 43.4 ± 1.39 
MCV (fL) 46.7 ± 0.92 49.2 ± 0.72 51.2 ± 0.65 46.20 ± 0.969 49.6 ± 0.31 50.9 ± 0.63 46.8 ± 0.61 48.4 ± 0.85 48.8 ± 0.91 46.4 ± 0.61 49.0 ± 1.11 49.2 ± 1.28 
MCH (pg) 16.4 ± 0.23 17.4 ± 0.17 17.2 ± 0.21 16.56 ± 0.260 17.6 ± 0.05 17.2 ± 0.21 15.8 ± 0.19 17.36 ± 0.268 17.0 ± 0.08 16.0 ± 0.25 16.5 ± 0.97 16.9 ± 0.36 
PLT (x10.e3 /uL) 1051.3 ± 
67.60 
941.5 ± 
86.33 
958.4 ± 
56.49 
981.2 ± 
100.79 
877.0 ± 
90.30 
962.5 ± 
70.52 
910.2 ± 
105.41 
1050.2 ± 
105.50 
971.6 ± 
136.42 
1161.2 ± 
95.86 
988.2 ± 
124.20 
946.5 ± 
59.12 
WBC (x10.e3/uL) 6.5 ± 0.89 6.4 ± 0.71 5.8 ± 0.66 6.7 ± 1.08 6.80 ± 1.653 7.2 ± 0.31 5.9 ± 0.29 5.1 ± 0.62 7.66 ± 1.37 5.3 ± 0.75 5.2 ± 1.67 6.1 ± 0.61 
All mean values were not significantly (P > 0.05) different from the control value. 
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Table 6: Average (mean ± s.d.) haematological values in Wistar male rats orally dosed with Grewia tenax whole fruit aqueous extract for 
90 days. 
 
  Group (1) Control Group (2) 10 gm / Kg.B.W.  Group (3) 15 gm / Kg.B.W.  Group (4) 20 gm / Kg.B.W.  
 Day (0) Day (45) Day (90) Day (0) Day (45) Day (90) Day (0) Day (45) Day (90) Day (0) Day (45) Day (90) 
RBC (x10.e6/uL) 5.9 ± 0.26 8.4 ± 0.17 9.20 ± 0.19 5.5 ± 0.38 8.0 ± 0.37 8.8 ± 0.11 5.8 ± 0.22 7.96 ± 0.147 7.8 ± 0.35  5.2 ± 0.31 8.4 ± 0.22 9.0 ± 0.11 
HGB (g/dL) 9.6 ± 0.48 14.7 ± 0.32 15.9 ± 0.34 8.9 ± 0.68 14.0 ± 0.16 15.2 ± 0.28 9.6 ± 0.59 13.9 ± 0.31 13.6 ± 0.67 8.2 ± 0.46 14.2 ± 0.38 15.3 ± 0.38 
HCT  (%) 27.5 ± 1.59 41.5 ± 1.18 47.5 ± 1.16 25.4 ± 2.20 39.5 ± 0.64 45.1 ± 0.93 28.3 ± 1.82 39.9 ± 1.09 40.0 ± 1.77 23.9 ± 1.62 39.7 ± 1.44 44.8 ± 1.33 
MCV (fL) 46.7 ± 0.92 49.2 ± 0.72 51.2 ± 0.65 46.2 ± 0.78 49.5 ± 0.57 51.3 ± 0.83 48.5 ± 1.58 50.1 ± 0.62 51.5 ± 0.50 45.9 ± 0.89 47.3 ± 0.67 49.5 ± 1.14 
MCH (pg) 16.4 ± 0.23 17.4 ± 0.17 17.2 ± 0.21 16.2 ± 0.23 17.5 ± 0.11 17.3 ± 0.27 16.4 ± 0.47 17.5 ± 0.10 17.5 ± 0.24 15.7 ± 0.31 17.0 ± 0.15 16.9 ± 0.31 
PLT (x10.e3 /uL) 1051.3 ± 
67.60 
981.5 ± 
46.33 
958.4 ±  
56.49 
1136.8 ± 
49.58 
924.4 ±  
87.85 
971.0 ± 
67.24 
1126.2 ± 
66.22 
1027.0 ± 
66.13 
911.0 ± 
91.75 
1081.0 ± 
 70.78 
945.8 ± 
45.91 
986.9 ± 
92.11 
WBC (x10.e3/uL) 6.5 ± 0.89 6.4 ± 0.71 5.8 ± 0.66 5.4 ± 0.73 7.0 ± 0.97 7.5 ± 1.13  5.2 ± 0.52 7.2 ± 0.49 6.7 ± 0.68 5.6 ± 0.61 6.8 ± 0.49 7.2 ± 0.98 
All mean values were not significantly (P > 0.05) different from the control value. 
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Table 7:  Average (mean ± s.d.) haematological values in Wistar female rats orally dosed with Grewia tenax whole fruit aqueous extract 
for 45 days. 
 
 Group (1) Control Group (2) 10 gm / Kg.B.W. Group (3) 15 gm / Kg.B.W. Group (4) 20 gm / Kg.B.W. 
 Day (0) Day (45) Day (90) Day (0) Day (45) Day (90) Day (0) Day (45) Day (90) Day (0) Day (45) Day (90) 
RBC (x10.e6/uL) 5.7 ± 0.3 7.9 ± 0.08 8.1 ± 0.10 6.2 ± 0.24 7.4 ± 0.25 8.2 ± 0.15 5.7 ± 0.11 7.8 ± 0.10 8.2 ± 0.11 5.7 ± 0.22 7.4 ± 0.26 8.5 ± 0.19 
HGB (g/dL) 9.8 ± 0.59 14.3 ± 0.10 15.2 ± 0.16 10.9 ± 0.55 13.8 ± 0.20 15.0 ± 0.14 9.8 ± 0.41 13.7 ± 0.14 13.3 ± 0.14 9.8 ± 0.56 13.3 ± 0.42  15.3 ± 0.36 
HCT  (%) 29.4 ± 1.73 41.0 ± 0.32 44.4 ± 0.51 32.8 ± 1.59 38.4 ± 1.52 44.0 ± 0.37 29.1 ± 0.99 39.3 ± 0.35 44.2 ± 0.56 29.2 ± 1.87 37.7 ± 1.08 44.5 ± 1.07 
MCV (fL) 52.0 ± 1.18 51.6 ± 0.45 54.1 ± 0.19 53.2 ± 1.01 51.8 ± 0.64 53.9 ± 0.69 51.2 ± 1.11 50.4 ± 0.43 53.8 ± 0.43 51.0 ± 1.78 50.9 ± 0.49 52.4 ± 0.48 
MCH (pg) 17.6 ± 0.36 18.0 ± 0.13 18.5 ± 0.081 17.7 ± 0.38 18.7 ± 0.76 18.4 ± 0.23 17.3 ± 0.48 17.6 ± 0.17 18.7 ± 0.21 17.1 ± 0.50 17.9 ± 0.14 18.1 ± 0.16 
PLT (x10.e3 /uL) 1214.2 ± 
95.61 
992.6 ± 
62.62 
1035.4 ± 
26.11 
1384.4 ± 
42.11 
1206.8 ± 
185.99 
1132.5 ± 
55.07 
1300.8 ± 
107.46   
1056.0 ± 
48.09  
1001.1 ± 
77.56  
1242.8 ± 
92.67  
883.6 ± 
92.00  
1038.5 ± 
94.81  
WBC (x10.e3/uL) 5.8 ± 0.52 6.4 ± 0.29 6.6 ± 0.56 5.1 ± 0.30 6.4 ± 0.80  6.4 ± 0.93 5.3 ± 0.86 7.1 ± 0.51 7.0 ± 1.10 6.2 ± 0.65 7.2 ± 1.14 7.0 ± 0.61 
All mean values were not significantly (P > 0.05) different from the control value. 
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Table 8: Average (mean ± s.d.) haematological values in Wistar female rats orally dosed with Grewia tenax whole fruit 
               aqueous extract for 90 days. 
. 
 Group (1) Control Group (2) 10 gm / Kg.B.W. Group (3) 15 gm / Kg.B.W. Group (4) 20 gm / Kg.B.W. 
 Day (0) Day (45) Day (90) Day (0) Day (45) Day (90) Day (0) Day (45) Day (90) Day (0) Day (45) Day (90) 
RBC (x10.e6/uL) 5.7 ± 0.31 7.9 ± 0.08 8.2 ± 0.10 6.3 ± 0.13 7.7 ± 0.22 8.0 ± 0.22 6.0 ± 0.23 7.2 ± 0.57 8.1 ± 0.06 5.8 ± 0.11 7.6 ± 0.12 8.3 ± 0.14 
HGB  (g/dL) 9.8 ± 0.59 14.3 ± 0.10 15.2 ± 0.16 11.3 ± 0.10 14.2 ± 0.19 14.9 ± 0.23 10.9 ± 0.51 13.5 ± 0.42 15.0 ± 0.18 10.5 ± 0.28 13.8 ± 0.12 15.4 ± 0.17 
HCT  (%) 29.4 ± 1.73 41.0 ± 0.32 44.4 ± 0.51 34.2 ± 0.21 41.0 ± 0.54 43.7 ± 0.73 32.7 ± 1.38 37.0 ± 3.10 44.0 ± 0.56 31.2 ± 0.90 39.6 ± 0.36 45.1 ± 0.56 
MCV (fL) 52.0 ± 1.18 51.62 ± 0.45 54.1 ± 0.19 54.2 ± 1.51 53.3 ± 0.98 54.9 ± 0.79 54.8 ± 0.92 51.5 ± 0.32 54.3 ± 0.34 53.6 ± 1.39 52.1 ± 0.81 54.6 ± 0.58 
MCH (pg) 17.6 ± 0.36 18.0 ± 0.13 18.5 ± 0.08 18.0 ± 0.56 18.4 ± 0.34 18.7 ± 0.27 18.3 ± 0.35 19.2 ± 1.28 18.5 ± 0.10 18.0 ± 0.44 18.1 ± 0.15 18.6 ± 0.18 
PLT (x10.e3 /uL) 1214.2 ± 
95.61 
992.6 ± 62.62 1035.4 ±  
26.11 
1295.8 ± 
86.39 
1170.4 ± 
 63.68 
1088.0 ± 
 73.38 
1136.2 ± 
152.84 
1149.6 ± 
 66.14 
1018.6 ± 
77.89 
1283.4 ± 
121.61 
1087.2 ± 
72.73 
1120.7 ± 
104.15 
WBC (x10.e3/uL) 5.8 ± 0.52 6.4 ± 0.29 6.6 ± 0.56 5.9 ± 0.79 7.7 ± 0.53 7.6 ± 1.21 6.1 ± 0.43 7.2 ± 1.58 7.0 ± 0.63 7.3 ± 1.05 7.0 ± 1.62 6.2 ± 0.99 
All mean values were not significantly (P > 0.05) different from the control value. 
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Table 9:  Average (mean ±  s.d.) biochemical values in wistar male rats orally dosed with Grewia tenax whole fruit aqueous 
extract for 45 or 90 days. 
 
Group 1 
(control) 
Group 2 (10 gm / Kg.BW) Group 3 (15 gm / Kg.BW) Group 4 (20 gm / Kg.BW)  
  A   B   A   B   A   B   
Blood urea 
nitrogen(mmol/L) 
9.87 ± 0.300 9.86 ± 0.587 10.10 ± 0.498 10.78 ± 0.306 10.76 ± 0.504 9.86 ± 0.468 9.60 ± 0.435 
Creatinine (µmol/L) 46.30 ± 4.182 47.40 ± 2.522 44.00 ± 4.593 37.40 ± 3.919  38.20 ± 5.997 49.99 ± 2.883 46.00 ± 0.894 
Total protein (g/L) 61.20 ± 1.200 61.40 ± 1.249 59.20 ± 2.608  58.20 ± 1.123  58.60 ± 1.470  58.90 ± 1.344 62.80 ± 1.374  
Albumin (g/L) 12.30 ± 0.213 13.00 ± 0.316 12.00 ± 0.837 12.20 ± 0.245 12.00 ± 0.316 12.85 ± 0.590 12.20 ± 0.200 
Alkaline phosphates 
(U/L) 
162.40 ± 10.813 167.00 ± 15.903 154.60 ± 7.011 167.40 ± 14.369 184.60 ± 4.343 168.00 ± 10.309 166.00 ± 21.055 
Aspartate 
aminotransferase (U/L) 
124.24 ± 7.427 112.80 ± 8.732 117.60 ± 8.593 126.00 ± 13.650  119.80 ± 12.482 119.77 ± 14.594  113.00 ± 2.530  
Alanine 
aminotransferase (U/L) 
67.10 ± 3.146 76.00 ± 8.562 87.00 ± 16.733 68.20 ± 12.504  72.60 ± 9.249  71.97 ± 6.228  66.60 ± 2.205 
Total iron binding 
capacity (µmol/L) 
80.97 ± 1.889 80.70 ± 2.489 76.44 ± 4.160 73.32 ± 2.229 80.00 ± 2.467 79.76 ± 1.090 82.30 ± 2.847 
Iron (µmol/L) 34.10 ± 0.809 35.60 ± 2.421 38.80 ± 3.056 26.40 ± 2.694 37.80 ± 1.855 35.63 ± 3.855 37.20 ± 4.630  
     Test means in a row are not significantly (P > 0.05) different from the control mean value.  
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Table 10:   Average (mean ±  s.d.) biochemical values in wistar female rats orally dosed with Grewia tenax whole fruit aqueous 
extract for 45 or 90 days. 
 
 Group 1 (control) Group 2 
 (10 gm / Kg.BW) 
Group 3 
 (15 gm / Kg.BW) 
Group 4  
(20 gm / Kg.BW) 
  A   B   A   B   A   B   
Blood urea 
nitrogen(mmol/L) 
8.95 ± 0.313 10.82 ± 0.447 10.80 ± 0.732  9.60 ± 0.445 10.96 ± 0.999 9.24 ± 0.573 9.22 ± 0.448 
Creatinine (µmol/L) 50.00 ± 1.054 48.20 ± 2.557 47.80 ± 2.478  55.00 ± 2.881 52.80 ± 1.594 50.60 ± 1.860 49.20 ± 2.634  
Total protein (g/L) 61.80 ± 0.917 63.20 ± 0.663 59.40 ± 1.123 60.60 ± 0.980 59.60 ± 2.112 60.00 ± 1.304 62.80 ± 0.583 
Albumin (g/L) 14.10 ± 0.348 14.20 ± 0.374 13.40 ± 0.245 13.80 ± 0.200 13.60 ± 0.748 13.40 ± 0.678 14.60 ± 0.400 
Alkaline phosphates 
(U/L) 
124.40 ± 10.010 121.00 ± 13.594 103.60 ± 17.848 111.00 ± 11.996 133.80 ± 11.115 139.60 ± 4.781 114.00 ± 10.964 
Aspartate 
aminotransferase (U/L) 
119.40 ± 9.600 126.20 ± 15.892 156.40 ± 26.030 157.80 ± 45.337 130.40 ± 16.666 157.60 ± 15.911 196.20 ± 30.269 
Alanine 
aminotransferase (U/L) 
70.10 ± 6.732 60.20 ± 3.527 78.00 ± 14.543 84.80 ± 25.097 65.80 ± 8.255 93.20 ± 6.674 98.20 ± 17.359 
Total iron binding 
capacity (µmol/L) 
91.44 ± 2.471 89.48 ± 2.612 86.02 ± 1.151 82.26 ± 2.109 86.98 ± 1.403 83.10 ± 2.187 92.70 ± 3.841 
Iron (µmol/L) 65.10 ± 2.456 64.40 ± 7.243 60.60 ± 3.829 55.20 ± 2.990 60.40 ± 2.482 52.60 ± 2.542 67.60 ± 6.088 
Test means in a row are not significantly (P > 0.05) different from the control mean value.  
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3.2 Safety and haematinic efficacy of the aqueous extract of Cajanus cajan 
seed in Wistar rats 
 
3.2.1 Clinical signs 
 According to daily close observations, all of the tested rats of both sexes, in 
groups 2, 3, 4, and in the control group, showed no toxicological symptoms  or 
clinical abnormality or change in behavior during the whole experimental 
period, which extended for three months. No mortalities were recorded 
throughout the period of the experiment.  
3.2.2 Changes in body weights and the weights of some internal organs 
In all tested and control groups, male and female rats increased similarly in their 
body weights according to their age (Figs. 7 and 8) till the end of the 
experiment. There were no significant (P> 0.05) differences between the various 
groups in body weights of rats at any time of weight determination. Weights of 
livers, kidneys, hearts and spleens of male and female rats of the different 
groups, showed no significant (P> 0.05) differences between groups 
respectively. (Tables 11 and 12) 
3.2.3 Pathological changes  
All tested and control groups of male and female rats showed no gross post-
mortem changes following the terminal slaughter 3 months post oral 
administration of Cajanus cajan aqueous extract at different dose levels. Normal 
appearance and texture of all internal organs were observed in all experimental 
groups.  
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   Figure: 7. Average growth curve of male Wistar rats orally dosed with Cajanus cajan 
whole seed extract for 45 or 90 days. 
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                 Figure: 8. Average growth curve of female Wistar rats orally dosed with Cajanus 
cajan whole seed extract for 45 or 90 days. 
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Table 11: Average (mean ± s.d) weights (gram) of some vital organs of male Wistar rats orally 
does with Cajanus cajan whole seeds aqueous extract for 45 or 90 days. 
  
 Group (1) control Group 2 (10 gm / kg.b.w.) Group 3 (15 gm / kg.b.w.)) Group 4 (20 gm / kg.b.w.) 
  A  B  A  B  A  B  
Liver  10.4 ± 0.31 11.0 ± 0.49 10.5 ± 0.45  10.2 ± 0.50 11.0 ± 0.84 11.3 ± 0.56 10.9 ± 0.31 
Kidney 2.3 ± 0.06 2.2 ± 0.12 2.2 ± 0.15 2.1 ± 0.21  2.2 ± 0.15 2.3 ± 0.16  2.4 ± 0.08  
Heart  1.0 ± 0.04 0.9 ± 0.08 1.1 ± 0.12 1.0 ± 0.02 0.9 ± 0.11 1.0 ± 0.07 1.1 ± 0.06 
Spleen  0.5 ± 0.02 0.5 ± 0.05 0.5 ± 0.07 0.5 ± 0.03 0.5 ± 0.07 0.5 ± 0.02 0.5 ± 0.03 
    All mean values of organs were not significantly (P > 0.05) different from the control value.  
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Table 12: Average (mean ± s.d) weights (gram) of some vital organs of female Wistar rats orally 
does with Cajanus cajan whole seeds aqueous extract for 45 or 90 days.  
 
 Group (1) control Group 2 (10 gm / kg.b.w.) Group 3 (15 gm / kg.b.w.)) Group 4 (20 gm / kg.b.w.) 
  A  B  A  B  A B 
Liver  7.0 ± 0.16 7.0 ± 0.13 7.6 ± 0.16 7.6 ± 0.25 7.1± 0.28 7.2 ± 0.04 7.1 ± 0.28 
Kidney 1.7 ± 0.03 1.7 ± 0.05 1.7 ± 0.05 1.7 ± 0.02 1.7 ± 0.04 1.7 ± 0.02 1.7 ± 0.04 
Heart  0.8 ± 0.02 0.8 ± 0.06 0.8 ± 0.05 0.8 ± 0.01 0.8 ± 0.03 0.8 ± 0.02 1.0 ± 0.03 
Spleen  0.4 ± 0.03 0.4 ± 0.06 0.4 ± 0.02 0.4 ± 0.07 0.4 ± 0.03 0.5 ± 0.04 0.4 ± 0.03 
    All mean values of organs were not significantly (P > 0.05) different from the control value.  
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3.2.4 Histopathological changes 
No histopathological changes were seen for all organs been examined for all 
tested and control groups of either sex.  
3.2.5 Hematological findings 
The complete blood counts for male and female rats groups, which were treated 
for 45 days (Table 13 and Tables 14 respectively), or 90 days (Table 15 and 
Table 16 respectively) showed no significant ( P>0.05) differences between 
mean values of all the hematological parameters (RBC, WBC and blood 
platelets counts, HCT percentage, MCV, and MCH) for the various groups 
treated with different dose levels of the aqueous extract of the seed of Cajanus 
cajan compared with the control group of the respective sex. 
3.2.6 Serum biochemical changes  
Table 17 for male rats and Table 18 for female rats illustrated that, all 
biochemical measured parameters ( concentration of iron, total iron binding 
capacity, total protein, and albumin.,the activities of alkaline phosphatase, 
aspartate aminotransferase and alanine aminotransferase) in the serum of test 
animals at the end of the experiment were not  significantly (P>0.05) different 
from control group. 
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Table 13: Average (mean ± s.d.) haematological values in Wistar male rats orally dosed with cajanus cajan 
whole seed aqueous extract for 45 days. 
 
 
                      All mean values were not significantly (P > 0.05) different from the control value. 
 
 
 
 
 
 
 
 Group (1) control  Group (2) 10 gm / Kg.B.W.  Group (3) 15 gm / Kg.B.W.  Group (4) 20 gm / Kg.B.W.  
 Day (0) Day (45) Day (90) Day (0) Day (45) Day (90) Day (0) Day (45) Day (90) Day (0) Day (45) Day (90) 
RBC 
 (x10.e6 / µL) 5.6 ± 0.14 8.3 ± 0.23 9.1 ± 0.07 6.1 ±  0.22 8.3 ±  0.18 9.1 ±  0.12 5.6 ± 0.21 8.7 ± 0.33 9.4 ± 0.25 5.4 ± 0.14 8.1 ± 0.14 9.57 ± 0.13 
HGB 
( g/ dL)  10.5 ± 0.37 14.4 ± 0.24 15.7 ± 0.11 11.8 ±  0.28 14.5 ±  0.24 15.5 ± 0.21 9.7 ±  0.60 
15.4 ±  
0.30 15.9 ±  0.24 9.5 ± 0.20 
 
14.6 ± 0.29 16.4 ± 0.22 
HCT 
( %) 34.9 ± 1.23 43.1 ± 1.23 46.6 ± 0.65 38.2 ±  1.50 44.5 ± 2.67 49.3 ± 2.63 32.1 ±  1.31 48.9 ± 2.04 50.9 ± 1.04
 
 30.9 ± 3.95 50.2 ± 3.37
 
 51.0 ± 1.84
 
 
MCV 
 (fL) 62.9 ± 1.41 51.9 ± 3.46 51.0 ± 2.56 62.4 ± 3.62 53.3 ± 2.49 54.1 ± 3.19
 
 57.2 ± 2.27 55.9 ± 1.40
 
 54.5 ± 1.71
 
 57.7 ± 3.97 55.4 ± 1.88 53.1 ± 2.45 
MCH 
 (pg)  19.0 ± 0.52 17.3 ± 0.28 17.2 ± 0.17 19.3 ± 0.24 17.3 ± 0.18 17.0 ± 0.24 17.2 ± 0.94 17.6 ± 0.46 17.0 ± 0.22 17.7 ± 0.37 18.5 ± 0.20 17.1 ± 0.08 
PLT 
 (x10.e3 /uL)   
750.3 ± 
77.18 
798.8 ± 
47.94 
813.3 ± 
19.51 
779.0 ± 
123.15 
817.0 ± 
77.96 
695.4 ± 
95.41 
792.2 ± 
128.88 
758.0 ± 
52.49 
609.0 ± 
48.84
 
 
774.8 ± 
80.93 
801.0 ± 
61.21 
646.0 ±  
63.92 
WBC 
 (x 10.e3 / µL)  6.7 ± 0.79 8.6 ± 0.68 10.4 ± 0.88 8.5 ± 0.51 8.6 ± 0.50 8.73 ± 0.742 8.7 ± 0.44 7.5 ± 0.36 8.7 ± 0.48 6.5 ± 0.26 8.6 ± 0.24 8.9 ± 0.65 
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Table 14: Average (mean ± s.d.) haematological values in Wistar male rats orally dosed with Cajanus cajan whole    
seed aqueous extract for 90 days. 
 
 Group (1) control  Group (2) 10 gm / Kg.B.W.  Group (3) 15 gm / Kg.B.W.  Group (4) 20 gm / Kg.B.W.  
 Day (0) Day (45) Day (90) 0 time At 45 days At 90 days 0 time At 45 days At 90 days 0 time At 45 days At 90 days 
RBC 
 (x10.e6 / µL) 5.6 ± 0.14 8.3 ± 0.22 9.1 ± 0.07 5.7 ± 0.08 7.7 ± 0.87 9.7 ± 0.10 5.4 ± 0.13 8.3 ±  0.33 9.4 ± 0.29 5.3  ±  0.16 8.3 ± 0.21 9.9 ± 0.20 
HGB 
( g/ dL)  10.5 ± 0.37 14.4 ± 0.24 15.7 ± 0.11 10.4 ± 0.19 13.8 ± 1.25 16.8 ± 0.23 9.6 ±  0.24 14.8 ±  0.28 15.9 ±  0.31 9.5 ± 0.32 14.5 ± 0.36 16.3 ± 0.32 
HCT 
( %) 34.9 ± 1.23 43.1 ± 1.23 46.6 ± 0.65 33.3 ± 0.35 40.2 ± 4.31 53.3 ± 0.83 30.9 ±  0.75 46.7 ±  1.21 49.1 ±  1.00
  30.2 ± 1.09 46.7 ± 1.84 50.6 ± 0.91  
MCV 
 (fL) 52.9 ± 1.41 51.9 ± 2.46 51.0 ± 1.56 55.0 ± 1.33 52.4 ± 1.82 55.1 ± 1.05 57.7 ±  1.33 55.2 ± 0.66 52.3 ± 0.80 56.9 ± 1.08 56.5 ± 2.85 51.2 ± 2.34
  
MCH 
 (pg)  19.0 ± 0.52 17.3 ± 0.28 17.2 ± 0.17 18.4 ± 0.47 18.2 ± 0.71 17.3 ± 0.21 17.9 ± 0.43 17.5 ± 0.33 16.9 ± 0.22 17.9 ± 0.36 17.6 ± 0.17 16.5 ± 0.24 
PLT 
 (x10.e3 /uL)  
750.3 ±  
77.18 
798.8 ± 
 47.94 
813.3 ±  
19.51 
688.4 ±  
47.54 
760.2 ± 
120.25 
699.0 ± 
65.79  
883.4 ± 
185.48 
776.2 ± 
58.95 
723.2 ± 
44.42 
884.6 ± 
120.28 
798.6 ± 
103.62 
770.8 ± 
43.314 
WBC 
 (x 10.e3 / µL)  6.7 ± 0.79 8.1 ± 0.68 10.4 ± 0.88 7.9 ± 0.28 10.1 ± 1.16 9.8 ± 1.04 7.5 ±  0.72 10.2 ±  0.49 11.7 ± 1.16 6.5 ± 1.11 10.3  ±  0.39 9.4  ±  0.74 
   All mean values were not significantly (P > 0.05) different from the control value. 
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Table 15: Average (mean ± s.d.) haematological values in Wistar female rats orally dosed with Cajanus cajan whole 
seed aqueous extract for 45 days. 
 
 Group (1) control Group (2) 10 gm / Kg.B.W. Group (3) 15gm / Kg.B.W. Group (4) 20 gm / Kg.B.W. 
 Day (0) Day (45) Day (90) Day (0) Day (45) Day (90) Day (0) Day (45) Day (90) Day (0) Day (45) Day (90) 
RBC 
 (x10.e6 / µL) 6.3 ± 0.13 7.8 ± 0.09 8.5 ± 0.30 6.1 ±  0.09  7.2 ±  0.52  7.9 ±  0.18  6.2 ±  0.03  8.0 ±  0.23  8.3 ±  0.10  6.2 ± 0.09 7.4 ± 0.13 8.1 ± 0.22 
HGB 
( g/ dL)  11.9 ± 0.23  13.8 ± 0.10  14.3 ± 0.10  11.4 ± 0.20  13.1 ±  0.60  14.2 ±  0.29  11.6 ±  0.19  13.7 ±  0.31  14.64 ±  0.273  11.3 ± 0.23 13.3 ±  0.26  14.3 ±  0.35  
HCT 
( %) 37.6 ± 0.68 40.1 ± 0.30  43.1 ± 0.49  37.1 ±  0.63  38.5 ± 2.60  43.9 ± 0.74  36.3 ±  0.72  42.7 ± 0.93  43.95 ± 1.451  35.7 ± 0.93 41.1 ± 1.26 43.9 ± 0.87 
MCV 
 (fL) 60.8 ± 0.44  52.1 ± 0.47 52.6 ± 0.68  60.9 ± 0.90  52.8 ± 0.64  55.2 ± 1.23  60.0 ± 0.48  53.3 ± 1.31  54.12 ± 1.108  60.0 ± 0.77 54.8 ± 1.04 55.9 ± 1.03 
MCH 
 (pg)  19.0 ± 0.12 17.8 ± 0.16  17.9 ± 0.18  19.0 ± 0.25  18.9 ± 0.53  18.2 ± 0.18  18.9 ± 0.18  17.9 ± 0.29  17.94 ± 0.228  18.9 ± 0.37  18.1 ± 0.24  18.0 ± 0.16 
PLT 
 (x10.e3 /uL)   
1010.2 ± 
62.15  
928.8 ± 
31.61  
918.8 ± 
42.67  
999.4 ± 
18.92  
891.6 ± 
89.65  
703.8 ± 
69.84  
957.8 ± 
32.98  
868.6 ± 
83.05  
789.20 ± 
 55.150  
817.8 ±  
136.88  
987.2 ± 
43.44  
798.0 ± 
39.09  
WBC 
 (x 10.e3 / µL)  7.1 ± 0.66 6.9 ± 0.45 7.1 ± 0.45  6.1 ±  0.19  6.2 ±  0.46  7.0 ±  0.54  5.8 ±  0.15  5.9 ± 0.15 8.4 ± 0.41  6.9 ± 0.68 7.4 ± 0.30 8.6 ± 0.40 
   All mean values were not significantly (P > 0.05) different from the control value. 
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Table 16: Average (mean ± s.d.) haematological values in Wistar female rats orally dosed with Cajanus cajan 
whole seed aqueous extract for 90 days. 
 
 Group (1) control Group (2) 10 gm / Kg.B.W. Group (3) 15gm / Kg.B.W. Group (4) 20 gm / Kg.B.W. 
 Day (0) Day (45) Day (90) Day (0) Day (45) Day (90) Day (0) Day (45) Day (90) Day (0) Day (45) Day (90) 
RBC 
 (x10.e6 / µL) 6.3 ± 0.13 7.8 ± 0.09 8.5 ± 0.30 6.4 ± 0.50 8.4 ± 0.86 9.0 ± 1.35 6.1 ± 0.07 7.6 ± 0.27 8.3 ± 0.26 6.1 ± 0.06 7.3 ± 0.39 8.0 ± 0.11 
HGB 
( g/ dL)  11.9 ± 0.23 13.8 ± 0.10 14.3 ± 0.10 11.9 ± 0.66 13.8 ± 0.21 13.9 ± 0.16 11.3 ± 0.37 13.5 ± 0.40 14.9 ± 0.39 11.6 ± 0.28 13.3 ± 0.45 14.5 ± 0.28 
HCT 
( %) 37.6 ± 0.68 40.1 ± 0.30 43.1 ± 0.49 36.4 ± 0.76 40.4 ± 1.03 43.2 ± 0.63 36.1 ± 1.22 41.6 ± 1.47 45.8 ± 1.50 35.8 ± 0.52 41.2 ± 2.23 42.8 ± 1.00 
MCV 
 (fL) 60.8 ± 0.44 52.1 ± 0.47 52.6 ± 0.68 60.8 ± 1.15 52.1 ± 0.54 55.5 ± 1.15 59.4 ± 1.26 53.9 ± 0.63 56.3 ± 0.71 60.0 ± 0.67 55.5 ± 0.83 55.4 ± 0.49 
MCH 
 (pg)  19.0 ± 0.12 17.8 ± 0.16 17.9 ± 0.18 19.1 ± 0.32 18.0 ± 0.33 18.0 ± 0.23 18.5 ± 0.46 18.0 ± 0.35 17.9 ± 0.18 19.0 ± 0.42 18.6 ± 0.46 17.9 ± 0.10 
PLT 
 (x10.e3 /uL)   
1010.2 ± 
62.15 
928.8 ± 
31.61 
918.8 ± 
42.67 
866.8 ± 
116.91 
936.0 ± 
61.11 
757.8 ± 
53.70 
783.6 ± 
143.52 
981.2 ± 
41.59 
743.0 ± 
48.22 
916.2 ± 
50.00 
807.2 ± 
92.70 
701.6 ± 
101.44 
WBC 
 (x 10.e3 / µL)  7.1 ± 0.66 6.9 ± 0.45 7.1 ± 0.45 8.8 ± 1.16 6.9 ± 0.77 7.8 ± 0.36 9.4 ± 1.02 8.4 ± 0.77 7.5 ± 1.29 8.0 ± 0.71 6.8 ± 0.81 9.0 ± 0.32 
  All mean values were not significantly (P > 0.05) different from the control value. 
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Table 17: Average (mean ±  s.d.) biochemical values in Wistar male rats orally dosed with Cajanus cajan 
whole seed aqueous extract for 45 or 90 days. 
 
  Test means in a row are not significantly (P > 0.05) different from the control mean value.  
 
 
 
 
 
Group (1) control Group (2) 10 gm / Kg.B.W. Group (3) 15gm / Kg.B.W. Group (4) 20 gm / Kg.B.W.  
 45 days  90 days  45 days  90 days  45 days  90 days  
Blood urea 
nitrogen(mmol/L) 
8.75 ± 0.580 9.86 ± 0.380 9.98 ± 0.520 9.46 ± 0.303 8.94 ± 0.293 8.68 ± 0.183 7.60 ± 0.609 
Creatinine (µmol/L) 44.70 ± 3.556 45.40 ± 2.502 44.60 ± 2.768 47.00 ± 2.000 42.60 ± 2.821 40.80 ± 3.826 42.80 ± 2.800 
Total protein (g/L) 68.00 ± 1.700 62.20 ± 1.356 67.40 ± 0.510 63.40 ± 1.806 64.20 ± 2.223 64.20 ± 1.281 62.20 ± 2.083  
Albumin (g/L) 14.60 ± 0.618 14.00 ± 0.447 14.60 ± 0.245 14.00 ± 0.316 14.00 ± 0.632 14.80 ± 0.374 13.00 ± 0.316 
Alkaline phosphates 
(U/L) 
176.40 ± 8.959 161.20 ± 13.264 178.80 ± 27.920 223.20 ± 16.992 159.40 ± 15.731 151.20 ± 2.746 154.60 ± 12.671 
Aspartate 
aminotransferase 
(U/L) 
118.20 ± 5.700 138.80 ± 12.504 119.20 ± 10.670 113.80 ±6.895 176.40 ± 39.503 160.40 ± 28.542 147.00 ± 18.089 
Alanine 
aminotransferase 
(U/L) 
83.90 ± 2.567 84.60 ± 5.428 77.80 ± 7.889 89.80 ± 6.151 92.40 ± 7.280 69.20 ± 5.607 73.60 ± 3.400 
Total iron binding 
capacity (µmol/L) 
113.30 ± 3.380 99.40 ± 2.522 102.60 ± 3.572 103.00 ± 3.660 109.20 ± 1.594 100.80 ± 4.164 101.20 ± 5.774 
Iron (µmol/L) 33.80 ± 1.652 29.60 ± 1.568 30.60 ± 1.503 31.00 ± 2.214 33.60 ± 2.839 28.40 ± 1.913 29.40 ± 2.272 
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Table 18: Average (mean ±  s.d.) biochemical values in wistar female rats orally dosed with Cajanus cajan 
whole seed aqueous extract for 45 or 90 days. 
 
  Test means in a row are not significantly (P > 0.05) different from the control mean value. 
 Group (1) control Group (2) 10 gm / Kg.B.W. Group (3) 15gm / Kg.B.W. Group (4) 20 gm / Kg.B.W. 
  A  B  A  B  A  B  
Blood urea 
nitrogen(mmol/L) 
9.82 ± 0.219  10.86 ± 0.880 11.38 ± 0.896 10.50 ± 0.461 10.72 ±  0.420  10.70 ± 0.428  10.96 ± 0.672  
Creatinine (µmol/L) 43.49 ± 0.906  47.25 ± 3.515 45.74 ± 0.823 43.85 ± 1.531 47.54 ± 1.963 44.05 ± 1.643  45.34 ± 1.920  
Total protein (g/L) 65.31 ± 0.584  70.46 ± 3.539 64.57 ± 0.610 67.66 ± 1.268 69.77 ± 1.769 64.46 ± 0.840  63.37 ± 1.534  
Albumin (g/L) 15.44 ± 0.311  16.63 ± 1.165 14.66 ± 0.700 15.83 ± 0.499 16.26 ± 0.721 14.63 ± 0.431  14.86 ± 0.405  
Alkaline phosphates 
(U/L) 
124.95 ± 10.331 157.82 ± 15.153 123.98 ± 12.846 149.42 ± 7.738 128.58 ± 16.212  145.42 ± 8.045 142.78 ± 9.915  
Aspartate 
aminotransferase 
(U/L) 
131.68 ± 6.365  139.86 ± 8.951 160.34 ± 13.223 155.26 ± 20.267 163.14 ± 31.217  160.66 ± 8.425 180.54 ± 30.787  
Alanine 
aminotransferase 
(U/L) 
88.86 ± 4.862  94.43 ± 4.028 111.15 ± 13.580 101. 43 ± 11.560 88.55 ± 7.819 107.03 ± 8.591 112.55 ± 14.858  
Total iron binding 
capacity (µmol/L) 
104.28 ± 0.850  113.87 ± 4.751 103.69 ± 2.930 107.27 ± 1.736 104.69 ± 2.478  109.67 ± 2.202 104.29 ± 5.323  
Iron (µmol/L) 59.40 ± 3.516  62.67 ± 9.464 58.21±4.856 60.87±7.681  64.41± 8.618  62.47± 10.558  55.21 ± 9.914   
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CHAPTER FOUR 
DISCUSSION 
 
The data presented in this study show that the oral administration of the aqueous 
extract of the fruits of Grewia tenax in male and female rats at doses of 10, 15 
and 20 gm/kg body weight did not result in any toxic effects. Daily close 
observation of all animals of both sexes in all groups revealed healthy with 
normal behaviors and vital signs. They increased steadily in their body weights 
with age in similar way throughout the study period. There were no significant 
differences in animals body weights in tested groups as compared with control 
groups of the male and female Wistar rats. At necropsy, three months after oral 
dosing, all the internal organs of tested and control groups exhibited normal 
texture and the appearance of all the inspected organs revealed no gross 
postmortem changes Appendix (1). 
 No significant differences were observed between the weights of organs of 
treated animals compared with the control groups and normal physiological wet 
weight in grams/100 g body weight  (Waynforth, 1980), Appendix (2). 
Histopathological examination confirmed the normal pictures of the organs, 
tissues and cells of all examined organs for all tested animals of various groups 
compared with the control groups. 
The complete blood counts for male and female rats groups showed no 
significant differences between mean values of all hematological parameters for 
tested animals at different dose levels compared with control group and normal 
physiological values of the sex, age and strain. HGB, RBC, HCT%, PCV, MCH, 
PLT, and WBC.  (Appendix 3 and Appendix 4) 
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Most toxicants interfere with enzyme system by denaturing the enzyme protein 
or by binding to the enzyme molecule and consequently inhibiting its activity 
(Aiello, 1998). So in order to evaluate the safety of the aqueous extracts of the 
fruit of Grewia tenax, liver and kidney functions tests were done. This due to 
the fact that liver is the most common site of toxic injury due to receiving about 
half of its blood supply from the portal vein, which drain blood from the 
gastrointestinal tract, and as a result toxic substances are absorbed into the portal 
blood and transported directly to the liver which is the organ most commonly 
involved with intoxication and detoxification. Also the liver undergoes 
metabolic biotransformation of many endogenous and exogenous substances 
before elimination from the body. This results in bioactivation of some 
substances into more toxic form which leads to hepatic injury (Jubb, et al., 
1985). Aqueous-soluble compounds tend to be excreted by the kidney so 
kidneys are also secreting urine for the purpose of elimination of metabolic 
wastes (Aiello, 1998). Therefore, the safety of the aqueous extract of the fruit of 
Grewia tenax has further been confirmed, through the determination of some 
serum biochemical parameters which have shown normal physiological values 
and no significant differences between the tested groups compared with control 
groups for all the estimated parameters. The concentration of blood urea 
nitrogen remained within the normal physiological value for Wistar breed rats at 
different dose levels including control groups. Also the concentration of 
creatinine, total protein, albumin, iron and total iron binding capacity (IBCT) 
which is a measure of the serum transferrin iron binding capacity, that widely 
used in the diagnosis and treatment of iron deficiency anemia and chronic 
inflammatory disorders (Tietz, 1994),  showed no significant differences 
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compared with control groups. All these parameters remained within the normal 
physiological values  
Appendix (5). Alanine aminotransferase (ALT) is a cytoplasmic enzyme that is 
considered as a liver-specific hepatocellular enzyme in dogs, cats, primates, rats 
and mice (Aiello, 1998), alkaline phosphatase (ALP) and aspartate 
aminotransferase (AST) which are present in the cytoplasm as well as in 
mitochondria and less specific than alanine aminotransferase as indicator for 
hepatic damage (Tennekoon, et al., 1991), also showed no significant 
differences between the mean values of different groups compared with control 
groups values and normal physiological values, Appendix (5). 
In the present study, although Grewia tenax fruit's aqueous extract did not 
induce notable change in the hematological parameters including heamoglobin 
concentration, RBCs counts and hematocrite percentages. The determination of 
these parameters is of great importance and helpful in evaluating iron deficiency 
anemia and iron status, because almost two-thirds of iron in the body is found in 
hemoglobin. Smaller amounts of iron are found in myoglobin, a protein that 
helps supply oxygen to muscle, and in enzymes that assist biochemical 
reactions. Iron is also found in proteins that store iron for future needs and that 
transport iron in blood (I.M.F.N.B., 2001). In the present study, iron and total 
iron binding capacities, which are very important tests in the diagnosis and 
evaluation of iron status when examined in blood serum for animals at the end 
of the experiment showed no significant difference between the mean values of 
tested animals at different dose levels compared with the control groups and 
normal physiological values. 
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 The obtained results are not in agreement with the traditional use of the fruits of 
Grewia tenax in Sudan (Northern and Southern parts of Kordofan region) to 
improve hemoglobin and the general health status and lactation of breast-
feeding mothers, as they are given in the form of nesha (A porridge prepared 
from Grewia tenax fruits sweetened drink by the addition of custard and flour) 
(F.F.N.C., 1998). 
Furthermore, Anttila et al.,(1993) reported that the milk production and 
reproduction of cattle and small stock had increased by eating of Grewia tenax 
plant. 
The aqueous extracts of Cajanus cajan at different dose levels in male and 
female rats did not result in any toxicological findings. These findings are 
indicated by the normal body weights gain according to the animal age, healthy 
animals' conditions, normal behaviors for all groups throughout the experiment, 
normal texture and appearance of all the internal organs at postmortem 
examinations (Appendix 6) and the normal histopathological findings. 
Biochemical analyses of serum parameters offered no significant difference 
between the various groups. The concentration of blood urea nitrogen remained 
within the normal physiological values at different dose levels including the 
control groups. Also the concentrations of creatinine, total protein, albumin, iron 
and total iron binding capacity showed no significant differences compared with 
control group. All these parameters remained within the normal physiological 
values Appendix (5). The activities of alkaline phosphatase, aspartate 
aminotransferase and alanine aminotransferase also showed no significant 
differences compared with the control groups. Therefore, the aqueous extract of 
the whole seed of Cajuns cajan may be considered safe. 
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The complete blood counts for male and female rats groups showed no 
significant differences between mean values of all hematological parameters for 
tested animals with the aqueous extract of the whole seed of Cajuns cajan at 
different dose levels compared with control groups and normal physiological 
values of the sex, age and strain. HGB, RBC, HCT%, PCV, MCH, PLT, and 
WBC for tested groups and control group remain within the normal 
physiological values, (Appendix 3 and Appendix 4).   
The present study was trying to evaluate the safety and hematinic efficacy of 
two plant products (The fruits of Grewia tenax and the whole seed of Cajuns 
cajan), which were claimed as effective folks medicinal treatments for iron 
deficiency anemia in the Sudan. This traditional use of the two plant products  
for the treatment of iron deficiency anemia may be related to the high content of 
Grewia tenax in iron (74 mg/kg) and the considerable amount of iron and 
vitamin C content of Cajanus cajan (15 mg/100g seed, 25 mg/100g; 
respectivly). Usually the absorption of dietary iron is influenced by the 
interaction of enhancers (ascorbic acid and meat), as well as by inhibitors 
(phytic acid, polyphenols and tannin, Ca, and Ca3(PO4)2), which determine the 
bioavailability of nonhaeme iron (Monson,1988). Iron stores are regulated by 
intestinal iron absorption (Miret, et al., 2003). However, the reason for the 
failure of Grewia tenax fruit and Cajanus cajan seeds preparations used in the 
present study in the improvement of hematological indices, might be related to 
the fact that healthy animals with normal blood values, rather than anemic 
animals were used. 
There are two forms of dietary iron: heme and nonheme. Heme iron is derived 
from hemoglobin, the protein in red blood cells that delivers oxygen to cells. 
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Heme iron is found in animal foods that originally contained hemoglobin, such 
as red meats, fish, and poultry. Iron in plant foods such as lentils and beans is 
arranged in a chemical structure called nonheme iron (Uzel and Conrad, 1998). 
This is the form of iron added to iron-enriched and iron-fortified foods. Heme 
iron is absorbed better than nonheme iron, but most dietary iron is nonheme iron 
(Miret, et al., 2003). 
 Iron absorption refers to the amount of dietary iron that the body obtains and 
uses from food. Healthy adults absorb about 10% to 15% of dietary iron, but 
individual absorption is influenced by several factors (Monson, 1988 and 
Davidson, 2003). Storage levels of iron have the greatest influence on iron 
absorption. Iron absorption increases when body stores are low. When iron 
stores are high, absorption decreases to help protect against toxic effects of iron 
overload (Bothwell, et al., 1979). Iron absorption is also influenced by the type 
of dietary iron consumed. Absorption of heme iron from meat proteins is 
efficient. Absorption of heme iron ranges from 15% to 35%, and is not 
significantly affected by the diet (Tapiero, et al., 2001). In contrast, 2% to 20% 
of nonheme iron in plant foods such as rice, maize, black beans, soybeans and 
wheat is absorbed (Siegenberg, et al., 1991). 
Nonheme iron absorption is significantly influenced by various food 
components (Monson, 1988). Meat proteins and vitamin C will improve the 
absorption of nonheme iron (Hunt, et al., 1994) Tannins (as in tea), calcium, 
polyphenols, and phytates can decrease absorption of nonheme iron (Brune, et 
al., 1989 and Hallberg, et al., 1991). It is most important to include foods that 
enhance nonheme iron absorption when daily iron intake is less than 
 76
recommended, iron losses are high , iron requirements are high, and when only 
vegetarian nonheme sources of iron are consumed. 
As many as 80% of the world's population may be iron deficient, while 30% 
may have iron deficiency anemia (Stoltzfus, 2001). Iron deficiency develops 
gradually and usually begins with a negative iron balance, when iron intake does 
not meet the daily need for dietary iron. This negative balance initially depletes 
the storage forms of iron while the blood hemoglobin level, a marker of iron 
status, remains normal. Iron deficiency anemia is an advanced stage of iron 
depletion. It occurs when storage sites of iron are deficient and blood levels of 
iron cannot meet daily needs. Blood hemoglobin levels are below normal with 
iron deficiency anemia  (I M F M B, 2001). Iron deficiency anemia can be 
associated with low dietary intake of iron, inadequate absorption of iron or 
excessive blood loss. 
The first step in iron deficiency treatment is elimination of the cause rather than 
diet. Therapeutic doses of iron supplements, which are prescribed for iron 
deficiency anemia, may cause gastrointestinal side effects such as nausea, 
vomiting, constipation, diarrhea, dark colored stools and/or abdominal distress 
(CDC, 1998). 
Treatment of iron deficiency anemia usually takes long time (from six months to 
one year), in addition to the possible side effects of iron therapy and the 
economic impact of this illness to the susceptible individuals and general public 
health and output. These facts may justify adoption and recommendation of 
these plant preparations as alternative methods of treatment and prevention of 
iron deficiency anemia, without any side effects and complications, because 
they already constitute a part of our Sudanese dietary culture. 
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Conclusion 
Grewia tenax fruit and Cajanus cajan seeds preparations are safe. They showed 
no toxic effects in Wistar rats. As normal rats were used in this study, the two 
plant preparations did not demonstrate hematinic efficacy on blood constituents 
especially heamoglobin concentration, red blood cells count, iron and iron 
binding capacity, in spite of their high contents of iron and the presence of 
vitamin C in the seeds of Cajanus cajan, which enhance iron absorption. Further 
investigations are needed to be conducted in anemic animals. 
 
Suggestions for further studies: 
1. Development of an animal model for iron deficiency anemia in rats. 
2. Determination of the hematinic active substances in the two plant 
preparations on extracts of the fruit of Grewia tenax and the seed of 
Cajanus cajan in various solvents. 
3. Determination of the hematinic efficacy of the two plant preparations in 
anemic animals. 
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Appendix 1 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Normal internal organs in Wistar rat orally dosed 
                    with Grewia tenax aqueous extract at dose Level  
of 20 gm/kg. b.w.  
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Appendix 2 
 
Organ weights (gm / 100 gm body wt.)  
 
Heart 0.4 
Lung 0.6 
Brain 1.0 
Liver 3.0 
Spleen 0.2 
Kidney (single) 0.4 
Adrenal (single) 0.02 
Testis (single) 0.5 
Ovary (single) 0.05 
Pituitary 0.005 
Pineal 0.001 
Stomach and intestine 2.3 
Thyroid 0.005 
Lymph node (popliteal) 0.002 
Thymus 0.07 
Prostate 0.16 
Seminal vesicles ( semen removed) 0.3 
 
Waynforth, (1980)
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Appendix 3 
 
Normal Hematological values for male Wistar rats. 
 
Age RBC 
(x10.e6/uL) 
HGB 
 (g/dL) 
HCT 
 (%) 
MCV (fL) MCH 
 (pg) 
PLT 
(x10.e3 /uL) 
WBC 
(x10.e3/uL) 
6 Weeks 5.22 – 6.27 
5.75 
11.5 -13.7 
12.6 
31.5 – 38.2 
34.8 
58 – 65 
61 
20.8 – 23.1 
22.0 
344 – 1070 
707 
7.7 -16.8 
11.3 
12 weeks 6.57 – 8.00 
7.29 
13.6 -16.2 
14.9 
37.7 – 45.9 
41.8 
55 – 62 
58 
18.9 – 22.1 
20.5 
507 -1118 
812 
4.4 – 14.2 
7.9 
18 weeks 6.95 – 9.57 
8.26 
13.1 – 16.7 
14.9 
35.5 – 47.7 
41.6 
48 – 53 
50 
17.0 – 19.2 
18.1 
627 – 898 
762 
3.4 – 8.6 
5.4 
Sanderson and Phillips, (1981).  
 
 
 
 
 
Appendix 4 
 
Normal Hematological values for female Wistar rats. 
Age RBC 
(x10.e6/uL) 
HGB 
 (g/dL) 
HCT 
 (%) 
MCV (fL) MCH 
 (pg) 
PLT 
(x10.e3 /uL) 
WBC 
(x10.e3/uL) 
6 Weeks 5.28 – 6.71 
5.99 
11.5 – 14.4 
12.9 
32.4 – 39.8 
36.1 
56 – 65 
61 
20.2 – 23.2 
21.7 
330 – 998 
663 
6.5 – 15.7 
10.1 
12 weeks 6.47 – 8.17 
7.32 
13.1 – 16.7 
14.9 
38.4 – 46.8 
42.6 
56 -63 
59 
18.9 – 22.0 
20.4 
448 – 979 
713 
3.7 – 10.4 
6.2 
18 weeks 7.14 – 8.36 
7.75 
13.7 – 15.8 
14.8 
37.9 – 45.7 
41.8 
51 – 57 
54 
17.5 – 20.8 
19.1 
450 – 921 
686 
2.5 -8.3 
4.6 
Sanderson and Phillips, (1981).  
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Appendix 5 
 
REFERENCE CLINICAL BIOCHEMISTRY VALUES 
  
  Protein    
SPECIES 
Urea 
mmol/L 
Total
g/L 
Albumin
g/L 
Globulin
g/L 
Aspartate 
Amino- 
transferase 
(AST,SGOT)
U/L 
Aspartate 
Amino- 
transferase  
(ALT,SGPT) 
U/L 
Alkaline 
Phosphatase 
RAT 
Wistar [Crl:(W)BR] 
11.42-19.28 
(14.64) 
63-86
(73) 
33-49 
(47) 
24-39 
(31) 
39-92 
(64) 
17-50 
(32) 
39-216 
(123) 
CCAC, 1993. 
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Appendix 6 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Normal internal organs in Wistar rat orally dosed  
with Cajanus cajan aqueous extract at dose level  
of 20 gm/kg. b.w.  
 
   ﻣﻠﺨﺺ اﻷﻃﺮوﺣﺔ
  
ﻔﻌﺎﻟﻴѧﺔ اﻟﻤﻘﻮﻳѧﺔ ﻟѧﺒﻌﺾ ﻣﻜﻮﻧѧﺎت اﻟѧﺪم ﻟﻠﻤѧﺴﺘﺨﻠﺺ اﻟﻤѧﺎﺋﻲ اﻟﺴﻼﻣﺔ و اﻟѧ اﻟﻬﺪف ﻣѧﻦ إﺟѧﺮاء هѧﺬﻩ اﻟﺪراﺳѧﺔ ﺗﻘѧﺼﻲ 
، ( أﺳѧﺎﺏﻴﻊ 6ﻋﻤѧﺮ ) ﻋﻠѧﻰ ﺟѧﺮذان اﻟﺘﺠѧﺎرب اﻟﺒﻴѧﻀﺎء ﺏﺘѧﺎن أﺟﺮﻳѧﺖ ﺗﺠﺮ . ﻟﺜﻤﺮة اﻟﻘﻀﻴﻢ وﺏѧﺬور اﻟﻠﻮﺏﻴѧﺎ اﻟﻌﺪﺳѧﻲ 
اﻟﻤﺴﺘﺨﻠﺼﻴﻦ اﻟﻨﺒﺎﺗﻴﻴﻦ، ﻗﺴﻤﺖ إﻟﻰ أرﺏﻌﺔ ﺣﻴﺚ اﺳﺘﺨﺪم ﻓﻲ آﻞ ﺗﺠﺮﺏﺔ أرﺏﻌﻴﻦ ﺟﺮذًا ﻣﻦ آﻼ اﻟﺠﻨﺴﻴﻦ ﻟﻜﻞ ﻣﻦ 
اﻟﻤﺠﻤﻮﻋѧﺔ اﻷوﻟѧﻰ ﺏﻘﻴѧﺖ ﻏﻴѧﺮ ﻣﻌﺎﻟﺠѧﺔ وهѧﻲ . ﻣﺠﻤﻮﻋﺎت ﻣﺘﺴﺎوﻳﺔ ﺗﺤﺘﻮى آﻞ ﻣﺠﻤﻮﻋﺔ ﻋﻠﻰ ﻋﺸﺮة ﺣﻴﻮاﻧﺎت 
 اﻟﻤѧѧﺴﺘﺨﻠﺺ اﻟﻤѧѧﺎﺋﻲ ﻟﺜﻤѧѧﺮة اﻟﻘѧѧﻀﻴﻢ أﻋﻄﻴѧѧﺖاﻟﻤﺠﻤﻮﻋѧѧﺔ اﻟѧѧﻀﺎﺏﻄﺔ ﺏﻴﻨﻤѧѧﺎ اﻟﻤﺠﻤﻮﻋѧѧﺔ اﻟﺜﺎﻧﻴѧѧﺔ واﻟﺜﺎﻟﺜѧѧﺔ واﻟﺮاﺏﻌѧѧﺔ 
 ﻋﻠѧﻰ اﻟﺘѧﻮاﻟﻲ وﻟﻤѧﺪة ( آﻐﻢ ﻣѧﻦ وزن اﻟﺤﻴѧﻮان /  ﺟﻢ 02، 51، 01)أوﺏﺬور اﻟﻠﻮﺏﻴﺎ ﻋﻦ ﻃﺮﻳﻖ اﻟﺘﺠﺮﻳﻊ اﻟﻔﻤﻮي 
  . ﻳﻮﻣًﺎ54
و ﺗﻢ ﺗﻜﻤﻠﺔ ﺗﺠﺮﻳﻌﻬﺎ ( أ)اﻟﻤﺠﻤﻮﻋﺔ , ﺗﻢ ﺏﻌﺪ ذﻟﻚ ﺗﻘﺴﻴﻢ آﻞ ﻣﻦ اﻟﻤﺠﻤﻮﻋﺎت اﻟﻤﻌﺎﻟﺠﺔ إﻟﻰ ﻣﺠﻤﻮﻋﺘﻴﻦ ﺙﺎﻧﻮﻳﺘﻴﻦ 
اﻟﺘѧﻲ ﺗﻮاﺹѧﻞ ﺗﺠﺮﻳﻌﻬѧﺎ ﺏﻮاﺳѧﻄﺔ اﻟﻤѧﺴﺘﺨﻠﺺ ( ب) أﺥѧﺮى، واﻟﻤﺠﻤﻮﻋѧﺔ ًﺎ ﻳﻮﻣѧ 54ﺏﻮاﺳﻄﺔ اﻟﻤﺎء اﻟﻤﻘﻄﺮ ﻟﻤѧﺪة 
ﺗﻤѧѧﺖ ﻣﺮاﻗﺒѧѧﺔ اﻷﻋѧѧﺮاض اﻹآﻠﻴﻨﻴﻜﻴѧѧﺔ .  أﺥѧѧﺮى ًﺎ ﻳﻮﻣѧѧ54 ﻟﻤѧѧﺪة  اﻟﻌﺪﺳѧѧﻲ ﻟﺜﻤѧѧﺮة اﻟﻘѧѧﻀﻴﻢ أوﺏѧѧﺬور اﻟﻠﻮﺏﻴѧѧﺎ اﻟﻤѧѧﺎﺋﻲ
 ﻋﻨѧﺪ ﺏﺪاﻳѧﺔ اﻟﺘﺠﺮﺏѧﺔ وﺏﻌѧﺪ  اﻟﻌﺪ اﻟﻜﺎﻣѧﻞ ﻟﻠѧﺪم ﺟﺮاءﻹأﺥﺬت أوزان اﻟﺤﻴﻮاﻧﺎت وﻋﻴﻨﺎت اﻟﺪم . واﻟﺴﻠﻮآﻴﺔ ﺏﺎﻧﺘﻈﺎم 
ﺪد آﺮﻳѧﺎت اﻟѧﺪم اﻟﺤﻤѧﺮاء ﻋѧ,  ﻳѧﻮم ﻋﻨѧﺪ ﻧﻬﺎﻳѧﺔ اﻟﺘﺠﺮﺏѧﺔ ﺣﻴѧﺚ ﺳѧﺠﻞ ﺗﺮآﻴѧﺰ اﻟﻬﻤﻮﺟﻠѧﻮﺏﻴﻦ 09 ﻳѧﻮم ﺙѧﻢ ﺏﻌѧﺪ 54
ﻣﺘﻮﺳѧﻂ اﻟﻬﻤﻮﺟﻠѧﻮﺏﻴﻦ ﻟﻠﺨﻼﻳѧﺎ اﻟﺤﻤѧﺮاء , اﻟﻨﺴﺒﺔ اﻟﻤﺌﻮﻳѧﺔ ﻟﻠﻬﻴﻤﺎﺗﻮآﺮﻳѧﺖ  , ﺘﺮاصﺣﺠﻢ اﻟﺨﻼﻳﺎ اﻟﻤ , واﻟﺒﻴﻀﺎء  
, ﻦاﻟﻜﺮﻳѧﺎﺗﻴﻨﻴ, اﻟﻴﻮرﻳѧﺎ)  ﺗѧﻢ ﺗﺤﻠﻴѧﻞ ﻣѧﺼﻞ اﻟѧﺪم ﻟﻜѧﺸﻒ ﺗﺮآﻴѧﺰ اﻟﻤﺆﺵѧﺮات اﻷﻳѧﻀﻴﺔ  .وﻋѧﺪد اﻟѧﺼﻔﺎﺋﺢ اﻟﺪﻣﻮﻳѧﺔ
اﻷﻻﻧѧѧѧѧѧﻴﻦ , اﻷﺳѧѧѧѧѧﺒﺎرﺗﻴﺖ أﻣﻴﻨѧѧѧѧѧﻮﺗﺮاﻧﺰﻓﻴﺮز) ﺒѧѧѧѧѧﺪ وﻧѧѧѧѧѧﺸﺎط ﺥﻤѧѧѧѧѧﺎﺋﺮ اﻟﻜ(  اﻟﺒѧѧѧѧѧﺮوﺗﻴﻦ اﻟﻜﻠѧѧѧѧѧﻲ واﻷﻟﺒﻴѧѧѧѧѧﻮﻣﻴﻦ
ﺗﻢ ﻓﺤѧﺺ . ﻴﺔ اﻟﻜﻠﻴﺔ ﻟﻠﺤﺪﻳﺪ ﻹرﺗﺒﺎﻃاﻘﺪرة اﻟوﻗﻴﺎس ﺗﺮآﻴﺰ ﻧﺴﺒﺔ اﻟﺤﺪﻳﺪ و ( أﻣﻴﻨﻮﺗﺮاﻧﺰﻓﻴﺮزواﻷﻟﻜﺎﻻﻳﻦ ﻓﻮﺳﻔﺎﺗﻴﺰ 
اﻟﻄﺤѧﺎل وﻧﺨѧﺎع اﻟﻌﻈѧﻢ ﻋﻨѧﺪ اﻟѧﺬﺏﺢ , اﻟﻘﻠѧﺐ , اﻟﻜﻠѧﻲ , ﺔ ﻣѧﻦ اﻟﻜﺒѧﺪ ﻴﺠﻴاﻷﻋѧﻀﺎء اﻟﺤѧﺸﻮﻳﺔ وأﺥѧﺬت ﻋﻴﻨѧﺎت ﻧѧﺴ 
                                                                                  .ﻟﻠﻔﺤﺺ اﻟﻨﺴﻴﺠﻲ اﻟﺪﻗﻴﻖ
أوﺽﺤﺖ اﻟﻨﺘﺎﺋﺞ اﻟﻤﺘﺤﺼﻠﺔ ﻟﻜﻼ اﻟﻨﺒﺘﺘﻴﻦ ﻋﺪم ﺳﻤﻴﺘﻬﻤﺎ إذ ﻟﻢ ﺗﻼﺣﻆ أي ﻋﻼﻣﺎت إآﻠﻴﻨﻴﻜﻴﺔ ﻣﺮﺽﻴﺔ أو ﺗﻐﻴѧﺮات 
   .(ﺙﻼﺙѧѧѧﺔ ﺵѧѧѧﻬﻮر) ﻟѧѧѧﻢ ﺗѧѧѧﺴﺠﻞ أي  وﻓﻴѧѧѧﺎت ﻃѧѧѧﻮل ﻣѧѧѧﺪة اﻟﺘﺠﺮﺏѧѧѧﺔ . ﺳѧѧѧﻠﻮآﻴﺔ ﻟﻠﺤﻴﻮاﻧѧѧѧﺎت أو ﻋﻼﻣѧѧѧﺎت ﺳѧѧѧﻤﻴﺔ
 ﻋﻨﺪ اﻟﺬﺏﺢ ﺏﺮهﻦ اﻟﻔﺤﺺ اﻟﺘﺸﺮﻳﺤﻲ ﻋﻠﻰ ﻋﺪم وﺟﻮد أي ﺗﻐﻴѧﺮات ﻓѧﻲ اﻷﻋѧﻀﺎء اﻟﺤﻴﻮﻳѧﺔ اﻟﺪاﺥﻠﻴѧﺔ أو ﺗﻐﻴѧﺮات 
                                       .ﻷﻋﻀﺎء أو اﻷﻧﺴﺠﺔ أو اﻟﺨﻼﻳﺎ ﻋﻨﺪ اﻟﻔﺤﺺ اﻟﻨﺴﻴﺠﻲ اﻟﺪﻗﻴﻖا  ﻓﻲﺳﻤﻴﺔ
ﻋﺔ اﻟѧﻀﺎﺏﻄﺔ وﻓѧﻲ اﻟﻤѧﺴﺘﻮى اﻟﻔѧﺴﻴﻮﻟﻮﺟﻲ  ﻟﻜﻞ ﻗﻴﺎﺳﺎت اﻟﻤﺠﻤﻮ ﻣﺸﺎﺏﻬﺔ آﺎﻧﺖ آﻞ اﻟﻘﻴﺎﺳﺎت اﻟﻜﻴﻤﻴﺎﺋﻴﺔ اﻟﺤﻴﻮﻳﺔ 
 ﻗﻴﺎﺳѧѧﺎت اﻟѧѧﺪم ﻟﻠﻤﺠﻤﻮﻋѧѧﺎت ﻣѧѧﺸﺎﺏﻬﺔﻟѧѧﻮﺣﻆ آѧѧﺬﻟﻚ . اﻟﻄﺒﻴﻌѧѧﻲ ﺏﺎﻟﻤﻘﺎرﻧѧѧﺔ ﻟﻘﻴﺎﺳѧѧﺎت آѧѧﻞ اﻟﺤﻴﻮاﻧѧѧﺎت اﻟﻤѧѧﺴﺘﺨﺪﻣﺔ 
 ﻟﻌѧﺪد آﺮﻳѧﺎت اﻟѧﺪم  ﻣﻌﻨﻮﻳѧﺔ اﻟﻤﻌﺎﻟﺠﺔ ﻣﻘﺎرﻧﺔ ﺏﺎﻟﻤﺠﻤﻮﻋﺔ اﻟﻀﺎﺏﻄﺔ، ﺣﻴﺚ ﻟﻢ ﺗﺤﺪث اﻟﻤﻌﺎﻟﺠﺔ أي ﺗﻐﻴﻴﺮ ذو ﻗﻴﻤѧﺔ 
 واﻟﻨѧﺴﺒﺔ اﻟﻤﺌﻮﻳѧﺔ ﺘѧﺮاص أو ﻋﺪداﻟﺼﻔﺎﺋﺢ اﻟﺪﻣﻮﻳѧﺔ وﺣﺠѧﻢ اﻟﺨﻼﻳѧﺎ اﻟﻤ اﻟﺤﻤﺮاء واﻟﺒﻴﻀﺎء أوﺗﺮآﻴﺰ اﻟﻬﻤﻮﺟﻠﻮﺏﻴﻦ 
 .                                          ﺎﻟﺠﺔ ﻣﻘﺎرﻧﺔ ﺏﺎﻟﻤﺠﻤﻮﻋﺔ اﻟﻀﺎﺏﻄﺔﻟﻠﻬﻴﻤﺎﺗﻮآﺮﻳﺖ ﻟﻠﻤﺠﻤﻮﻋﺎت اﻟﻤﻌ
ﺥﻠﺼﺖ اﻟﺪراﺳﺔ إﻟﻰ ﺳﻼﻣﺔ وﻋﺪم ﺳﻤﻴﺔ أي ﻣﻦ اﻟﻨﺒﺘﺘﻴﻦ اﻟﻤﺴﺘﺨﺪﻣﺘﻴﻦ وﺏﺎﻟﺮﻏﻢ ﻣѧﻦ ﻋѧﺪم إﺣѧﺪاث اﻟﻨﺒﺘﺘѧﻴﻦ ﻷي 
ﺮات ﻓﻲ ﻣﻜﻮﻧﺎت اﻟﺪم ذات اﻟﻌﻼﻗﺔ ﺏﺄﻧﻴﻤﻴﺎ ﻧﻘﺺ اﻟﺤﺪﻳﺪ ﺏﺎﻟﺮﻏﻢ ﻣﻦ  وﺟﻮد آﻤﻴﺔ آﺒﻴﺮة و ﻣﻘﺪرة ﻣﻦ ﻋﻨﺼﺮ ﺗﻐﻴ
 وآѧﻼ ( ﺟѧﻢ 001/  ﻣﻠﺠѧﻢ 0.51) وﺏѧﺬور اﻟﻠﻮﺏﻴѧﺎ (آﺠﻢ ﻣﻦ اﻟﺜﻤѧﺎر اﻟﺠﺎﻓѧﺔ /  ﻣﻠﺠﻢ 47)اﻟﺤﺪﻳﺪ ﻓﻲ ﺙﻤﺎر اﻟﻘﻀﻴﻢ 
 أن اﻟﺤﻴﻮاﻧﺎت اﻟﻤﺴﺘﺨﺪﻣﺔ ﻓﻲ هѧﺬﻩ و ﺏﻤﺎ .اﻟﻤﺤﺘﻮﻳﻴﻦ ﻣﻦ اﻟﺤﺪﻳﺪ ﻳﺘﺠﺎوز ﻣﻌﺪل اﻹﺣﺘﻴﺎج اﻟﻴﻮﻣﻲ ﻟﻌﻨﺼﺮ اﻟﺤﺪﻳﺪ
 ﻋﻠﻰ اﻟﺮﻏﻢ ﻣѧﻦ واﻟﺪراﺳﺔ آﺎﻧﺖ ﺳﻠﻴﻤﺔ ذات ﻣﻌﺪل ﻃﺒﻴﻌﻲ ﻟﻜﻞ ﻣﻜﻮﻧﺎت اﻟﺪم ذات اﻟﻌﻼﻗﺔ ﺏﺄﻧﻴﻤﻴﺎ ﻧﻘﺺ اﻟﺤﺪﻳﺪ 
  ,ﻓѧﻲ ﺏѧﺬور اﻟﻠﻮﺏﻴѧﺎ ( ﻓѧﺎﻳﺘﻤﻴﻦ ج ) وﺟѧﻮد ﻣﺤﻔѧﺰ اﻻﻣﺘѧﺼﺎص ﻣﻊوﺟﻮد اﻟﺤﺪﻳﺪ ﺏﺘﺮاآﻴﺰ ﻋﺎﻟﻴﺔ ﻓﻲ آﻼ اﻟﻨﺒﺘﺘﻴﻦ و 
ء دراﺳﺎت ﻣﺴﺘﻘﺒﻠﻴﺔ ﻻﺳﺘﻘﺼﺎء اﻟﻔﻌﺎﻟﻴﺔ اﻟﻤﻘﻮﻳﺔ ﻟﺒﻌﺾ ﻣﻜﻮﻧﺎت اﻟѧﺪم ﻟﺬﻟﻚ ﺗﻮﺹﻲ هﺬﻩ اﻟﺪراﺳﺔ ﺏﻀﺮورة إﺟﺮا 
  . ﻟﻜﻼ اﻟﻨﺒﺘﺘﻴﻦ ﻓﻲ ﺣﻴﻮاﻧﺎت ﺏﻌﺪ إﺣﺪاث أﻧﻴﻤﻴﺎ ﻧﻘﺺ اﻟﺤﺪﻳﺪ ﺏﻬﺎ ﺗﺠﺮﻳﺒﻴًﺎ
  دراﺳﺔ ﺳﻼﻣﺔ ﺛﻤﺮة اﻝﻘﻀﻴﻢ وﺑﺬور اﻝﻠﻮﺑﻴﺎ وﺗﺄﺛﻴﺮهﻤﺎ ﻋﻠﻲ
 ﻣﻜﻮﻧﺎت اﻝﺪم ﻓﻲ ﻓﺌﺮان اﻝﺘﺠﺎرب
  إﻋﺪاد
 هﺪى أﺣﻤﺪ أﺑﻮﻋﺮآﻲ أﺣﻤﺪ
  اﻝﺰﻗﺎزیﻖ( 6891)ﻝﻄﺒﻴﺔ اﻝﺒﻴﻄﺮیﺔ ﺑﻜﺎﻝﺮیﻮس اﻝﻌﻠﻮم ا
رﺳﺎﻝﺔ أﻋﺪت وﻓﻘًﺎ ﻝﻤﺘﻄﻠﺒﺎت ﺝﺎﻣﻌﺔ اﻝﺨﺮﻃﻮم ﻝﺪرﺝﺔ اﻝﻤﺎﺝﺴﺘﻴﺮ ﻓﻲ اﻝﻌﻠﻮم اﻝﻄﺒﻴﺔ 
 اﻝﺒﻴﻄﺮیﺔ
  (اﻝﺴﻤﻮم اﻝﺒﻴﻄﺮیﺔ) 
 
  :اﻝﻤﺸﺮف
  ،ﺳﺎﻣﻴﺔ ﻣﺤﻤﺪ ﻋﻠﻲ اﻝﺒﺪوي. د
  ، آﻠﻴﺔ اﻝﻄﺐ اﻝﺒﻴﻄﺮي–ﻗﺴﻢ اﻝﻄﺐ واﻷدویﺔ واﻝﺴﻤﻮم 
  .ﺝﺎﻣﻌﺔ اﻝﺨﺮﻃﻮم
  
  :اﻝﻤﺸﺮف اﻝﻤﺴﺎﻋﺪ
  ،ﺒﻜﻲ ﺥﺎﻝﺪﺣﺴﻦ اﻝﺴ. د
  ، اﻝﻤﻌﻬﺪ اﻝﻘﻮﻣﻲ ﻝﻠﺒﺤﻮث–واﻝﻌﻄﺮیﺔ اﻝﻨﺒﺎﺗﺎت اﻝﻄﺒﻴﺔ 
  .اﻝﺨﺮﻃﻮم
 آﻠﻴﺔ اﻝﻄﺐ اﻝﺒﻴﻄﺮي، 
 ﺝﺎﻣﻌﺔ اﻝﺨﺮﻃﻮم،
 
 6002ﺳﺒﺘﻤﺒﺮ 
